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ABSTRACT
THE RETINA-PROSTHESIS INTERFACE IN TWO RAT MODELS
OF RETINITIS PIGMENTOSA AND FUNCTIONAL CHANGES
ASSOCIATED WITH PHOTORECEPTOR LOSS
James W. Fransen
June 28th, 2013
With increasingly successful clinical trials, the use of prosthetic devices to
replace the function of photoreceptors has now become a viable option to treat
degenerative diseases of the retina, including age-related macular degeneration
(AMD) and retinitis pigmentosa (RP). Using prosthetics, patients have
demonstrated the ability to read large text, recognize small objects, and navigate.
While promising, this represents coarse visual function, with the highest visual
acuity equivalent to 20/560, still below the legal definition of blindness, 20/200.
To investigate the benefit of more sophisticated designs, I implanted two types of
photovoltaic prosthetic devices in two models of RP, Tg S334ter-3 and Tg P23H1 rats. The performance of a new bipolar photovoltaic array (bPVA) design with
local ground returns was compared to a monopolar photovoltaic array (mPVA)
with a single ground return. Regardless of implant design, stimulation parameters
at threshold were at least 1.5 orders of magnitude below safety limits. Age and
duration of implantation had no significant effect on stimulation thresholds while
threshold increased inversely to pixel size.
iv

In addition to treating the symptoms of these diseases, a better
understanding of the functional consequences of degeneration will help guide
future treatment strategies. I examined changes in visual function in the retina
and the superior colliculus (SC). I found profound changes in visual function in
both models. First, the ON pathway is preferentially lost due to a shift from equal
numbers of ON and OFF ganglion cells in the retina and ON dominated
responses in the SC to OFF dominated responses in both. In the Tg P23H-1 rat,
this shift is progressive with age, while in the Tg S334ter-3 this shift is evident
early in life. In late stages of the disease, there is little response from the ON
pathway. In animals implanted with bPVA devices, there was a significant
change in the response based on the location of the prosthesis, with a
preservation of the ON pathway in areas directly under the influence of the
prosthesis. Either the presence of the device or basal electrical activity may
induce a trophic influence that attenuates this change in visual function.
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CHAPTER I
INTRODUCTION AND GENERAL
BACKGROUND INFORMATION
Regardless of species, the need for an organism to gather information
about its environment is universal. Tactile, chemical, and photic stimuli have all
driven the evolution of different sensory modalities to best detect stimuli
contained in an organism’s natural environment. The ability to detect light, food
sources and environmental danger led to the development of visual systems
early in evolutionary history. Early vision was likely very simple, consisting of little
more than aggregations of proteins in bacteria that drove phototaxis. These
proteins were able to change conformation in response to the presence or
absence of light. Providing feedback to the organism, this change could then be
used to drive the bacterium towards or away from a source of light depending on
the needs of the organism (Suzuki et al., 2010).This rudimentary system evolved
along with the diversity of life over billions of years to provide more thorough and
sophisticated visual information regarding the environment. The study of the
visual system has revealed an exquisitely tuned system for collecting and
interpreting visual signals in the specific environment of a species. Visual
systems have evolved to the circadian cycle, food source, predatory species, etc.
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contained in an organism’s specific environment. For example, bees (Skorupski
and Chittka, 2010) and mice (Jacobs et al., 1991) can detect light in the ultraviolet (UV) spectrum, below the visible wavelengths of humans. This sensitivity to
UV wavelengths increases the bee’s ability to find specific food sources in the
form of flowers that reflect UV light. The visible spectrum for humans is at least
partially tied to food source as well. In a similar fashion, it is hypothesized that
humans developed color perception at least in part to better assess the ripeness
of fruits and vegetables, which is related to its nutritional value (Lucas et al.,
2003). These are but a small fraction of examples that could be used to highlight
the importance of the visual system to most organisms. Given the importance of
environmental stimuli to an organism, deficits in any sensory system can be
devastating. Within the visual system, mutations in the proteins that begin the
process of phototransduction can lead to debilitating visual deficits or even
complete blindness. The general goals of this dissertation are to assess a
potential treatment for blinding eye diseases in the form of retinal prosthetic
devices, describe functional changes that occur in the retina and its first synapse
as a result of photoreceptor degenerative processes, and address the possibility
that implantation of a prosthetic device may impart a neuroprotective effect on
the function of these retinas.
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The Visual System and Phototransduction
Retinal Structure and Cell Classes
The retina is a neural structure that
contains five general cell classes. These
cells form a laminar structure in which three
cellular layers alternate with two plexiform
(synaptic) layers (Figure 1). The
photoreceptor cell bodies form the first
cellular layer, the outer nuclear layer (ONL).
In the outer plexiform layer (OPL),
photoreceptors synapse with cells of the
inner nuclear layer (INL), namely the
bipolar cells (BCs) and the horizontal cells

Figure 1. Laminar structure of the
vertebrate retina. Modified from
webvision.med.utah.edu.

(HCs), which modulate the photoreceptor
output. The BCs provide the excitatory drive to amacrine cells (ACs), also located
in the INL and both BCs and ACs synapse onto retinal ganglion cells (RGCs) in
the inner plexiform layer (IPL). RGCs are projection neurons whose axons exit
the back of the eye to form the optic nerve and transmit signals to the visual
centers of the brain.

Phototransduction
Phototransduction is the conversion of light into an electrical signal within the
photoreceptor. Photosensitivity within photoreceptors arises due to the presence
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of photopigments, called opsins, in the outer segment (OS) (Figure 2). In the
dark, cGMP-gated cation channels in the photoreceptor outer segments are in an
open state. Current flows into the outer segment (the ‘dark current’), the
photoreceptors depolarize and in the dark release glutamate. In the inactive
state, opsin proteins are bound to a trimeric g-protein, called transducin, which is
composed of an alpha, beta, and gamma subunit. In the dark, GDP is attached to
the alpha subunit and keeps it bound to the beta and gamma transducin
subunits. When a photoreceptor absorbs a photon, 11-cis retinal changes
conformation to all-trans form and activates rhodopsin. Once rhodopsin is
activated, the GDP bound to the alpha transducin subunit is phosphorylated to
GTP and the alpha subunit is released. The now activated alpha subunit is free
to bind and activate cGMP phosphodiesterase. This enzyme catalyzes the
hydrolysis of cGMP to a non-cyclic form, with the decrease in cGMP closing the
cation channels and hyperpolarizes the photoreceptor. This decreases glutamate
release in a graded fashion, proportional to the light energy (Figure 2).
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A.

B.

Figure 2. A. Structure of cone and rod photoreceptors. B. The elements of the
phototransduction cascade. Adapted from: Left: The Visual Neurosciences
(Chalupa and Werner). Right: Purves et al., 2001.

There are two classic types of retinal photoreceptors: rods and cones.
Because of their differential sensitivity to light, these two types give the retina the
ability to work over a luminance range of about 12 orders of magnitude. The rods
are more sensitive than the cones, with the ability of a rod to respond to a single
absorbed photon (Baylor et al., 1979). To achieve high sensitivity, rods pool their
signals at subsequent synapses, but the consequence is poor spatial resolution
under rod driven vision. Therefore, rods are utilized under low light conditions
when the ability to detect light and movement are more important than resolution.
Cones are active during higher ambient light conditions and their nearly “one to
one” synaptic connections in the fovea result in high acuity. Because cones can
express one of two or three opsins (depending on the species) with different
spectral sensitivities, they initiate color perception.
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Normal Retinal Signaling
The photoreceptor's reduction in glutamate release causes a change in the
polarization of their postsynaptic partners, the BCs and HCs. The sign of the
polarization depends on the type of glutamate receptor expressed by the HCs
and the ten morphological types of BC. There are four morphological types of
OFF cone BCs which express ionotropic glutamate receptors (iGluRs), which are
comprised of a cation channel with a glutamate receptor binding site. iGluRs
open when glutamate binds and depolarize then quickly desensitize due to the
properties of the channel. When glutamate concentrations in the synapse are low
(in the light), the iGluR channel is closed, similar to the closure of the channels in
the photoreceptor. This means that the OFF BCs conserve the sign of the
photoreceptor signal (hyperpolarization) to light and depolarize at the onset of a
luminance decrement.
There are five types of ON cone BCs and one type of ON rod BC that express
metabotropic glutamate receptor type 6 (mGluR6), which is a G-protein coupled
receptor. When glutamate concentrations are low in the synapse, a G-protein
cascade is inhibited and the non-specific cation channel, TRPM1, is opened. In
the dark when glutamate concentrations are high, the G-protein cascade is
initiated which closes the TRPM1 channel. In this way, ON BCs invert the sign of
the photoreceptor signal; when the photoreceptor is hyperpolarized, the BC will
depolarize. At this first synapse, the opposite BC responses create the ON (BCs
with mGluRs) and OFF (BCs with iGluRs) parallel signaling pathways within the
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retina. At this synapse, horizontal cells use feedback inhibition to modulate
photoreceptor output and to generate an inhibitory surround in the BCs.
Within the cone pathway, photoreceptors signal to ON and OFF cone BCs,
which synapse directly onto RGCs and generate an excitatory input via
glutamate release. Rod BCs are ON BCs, but do not directly synapse onto
RGCs. Instead, they utilize a narrow field bistratified
AC, the AII AC, as an intermediary to provide input to
both the ON and OFF cone pathways but the AII
connects to each with a different mechanism. The AII
AC connects to ON cone BCs through a gap junction,
creating a signal of the same sign as the presynaptic
input. The AII connects to OFF cone BCs or OFF
RGCs via an inhibitory synapse, releasing glycine to
inhibit the OFF pathway (Figure 3). With these

Figure 3. The rod signaling
pathway. Rod photoreceptors
provide synaptic input to rod
connections the AII AC is able to convey information
BCs. These interneurons
connect to both the On
to both pathways: excitation to the ON pathway and
pathway via the AII amacrine
cell. The AII makes a gap
inhibition to the OFF pathway during rod driven vision. junctional contact with OFF
BCs, while it makes a
BCs signal to RGCs via glutamate and ACs modulate glycinergic synaptic contact
with ON cone BCs. r=rod,
the BC signal via a number of inhibitory mechanisms c=cone, rb=rod BC, cb=cone
BC, AII=AII AC, gc=RGC. From
Manookin et al., 2008.
and using the neurotransmitters GABA or glycine.
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The Superior Colliculus
The superior colliculus (SC) is a subcortical structure that is a direct synaptic
target of RGC axons. In mice, it is estimated that at least 70% of RGCs make
synaptic connections with cells in the SC (May, 2006). The SC is organized as a
laminar structure. The superficial (dorsal) layers receive synaptic input primarily
(~95-98%) from contralateral RGC axons, whereas the more ventral layers
process other sensory modalities or integrate multi-sensory information (May,
2006). The most likely function of the SC is to direct attention towards a novel or
moving stimulus (Robinson, 1972). For most animals, this plays a vital role in the
ability to spot prey or avoid predators. The SC provides input to the lateral
geniculate nucleus (LGN) (Hoffman, 1973), another direct synaptic target of RGC
axons, and receives input from the primary visual cortex (Lund, 1964). These
connections lead to the hypothesis that the SC likely has a modulatory role for
image formation and is modulated by the input from V1, although the specific
functions of these connections are not as well understood.
The axons of the RGCs form a topographic map of the retina on the dorsal
surface of the SC (Figure 4). This means adjacent RGCs within the retina
synapse at adjacent points across the SC dorsal layers (Drager and Hubel,
1976). This spatial information about regional changes within the retina also can
be used to localize the area of the retina that is stimulated by a prosthetic device.
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Figure 4. Retinal
projections to the
dorsal surface of the
left SC. Labels inside
the diagram represent
the projections from
RGCs. Labels outside
the diagram represent
the spatial layout of the
SC surface.

Anterior

Retinitis Pigmentosa and Rat Models of RP
Causes of RP
Retinitis pigmentosa is a group of disorders characterized by the loss of
rod photoreceptors and in many cases, subsequent loss of cone photoreceptors.
The majority of cases of RP result from mutations in rhodopsin or its signaling
cascade. This can lead to difficulty with peripheral vision or low light vision, such
as driving at night, which typically are the first symptoms that push patients to
see their doctor. Upon examination, the typical signs of RP in the fundus include
bone spicule formation, arteriolar atrophy and optic disc pallor, which are
accompanied by a reduced electroretinogram (ERG) response (Fishman et al.,
1988; Figure 5).
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Figure 5. A: Fundus image of normal retina. B: Fundus image of advanced RP
patient, note the appearance of bone spicules, optic disc pallor, and blood
vessel atrophy. Modified from webvision.med.utah.edu

While many patients present with similar signs and symptoms, the genetic
cause varies extensively. Mutations in a number of different genes cause RP, for
example, mutations in rhodopsin (Dryja et al., 1990), in genes expressed by the
retina pigment epithelium (RPE) (Thompson et al., 2002), in photoreceptor
transcription factors (Martinez-Gimeno et al., 2001), and in accessory proteins
associated with photoreceptors (Kimberling et al., 1990). Even with the reduced
price and increased access of genetic testing to the public, up to 40% of genetic
causes of RP remain unknown (Hartong et al., 2006). In addition, RP is inherited
in multiple ways; some are autosomal dominant (ADRP), others autosomal
recessive or X-linked. This heterogeneity in mutation and inheritance means that
any potential genetic therapy approach is unlikely to be universally applicable. As
a consequence, other therapeutic approaches are being developed to treat RP.
They include: neuroprotection to delay degeneration, cellular therapies with the
hope of replacing lost photoreceptors, optogenetic expression of bacterial
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channel opsins to replace lost photoreceptor function and finally, prosthetic
devices (including retinal, optic nerve, LGN and cortical).

Transgenic (Tg) P23H-1 and S334ter-3 Rat Models of RP
Once the genetic causes of RP started to be defined, multiple animal
models of RP were found or created using molecular manipulation. These
include mice (Olsson et al., 1992, McNally et al., 2002, Price et al., 2011), rats
(Bok and Hall 1971, Lewin et al., 1998, Liu et al., 1999), rabbits (Kondo et al.,
2009) and pigs (Petters et al., 1997, Ross et al., 2012). Two Tg rat models (with
multiple lines in each) that express rhodopsin mutations, P23H and S334ter have
been widely used. The Tg P23H-1 rat results from a single point mutation that
alters the 23rd amino acid residue in rhodopsin from a proline to a histidine in the
mutated protein (Lewin et al., 1998). This amino acid change prevents the mutant
rhodopsin from folding properly. Deficiencies in the ubiquitin protease system
associated with these mutations lead to the accumulation of the mutant protein in
the photoreceptor cell body and cause apoptosis (Illing et al., 2002). The P23H
mutation is the most common form of ADRP in North America, accounting for
12% of all cases (Dryja et al., 1990).
The Tg S334ter-3 rat results from a point mutation that causes an early
stop codon at the 334th residue, normally a serine (ucsfeye.net). This change
results in the expression of a truncated rhodopsin protein in which 15 amino
acids are lost from the C-terminus, which results in the inability to properly traffic
rhodopsin to the outer segments (Concepcion et al., 2002). Like mutant P23H
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rhodopsin, this protein also accumulates in the photoreceptor cell body and
causes apoptosis (Shinde at al., 2012). Within each model there are multiple
lines distinguished by their different rates of degeneration, which most likely
arises from positional effects of transgene insertion and differential expression of
the transgene. Line number is designated at the end of the name, for example Tg
P23H-1 represents line 1.
Both Tg P23H-1 and Tg S334ter-3 models show initial rod photoreceptor
death followed by cone photoreceptor death at later stages, much like the course
of human RP. Both models show autosomal dominant inheritance patterns,
similar to some human RP patients. These models were chosen, for my
experiments in order to contrast and compare a fast (Tg S334ter-3) and a slow
degeneration line (Tg P23H-1). The rates of degeneration have been measured
morphologically using ONL thickness (Figure 6;
ucsfeye.net/mlavailRDratmodels.shtml).

Figure 6. Degeneration rates differ across Tg P23H and Tg S334ter
rat lines. Tg P23H line 1 and Tg S334ter line 3 rats were used for my
experiments. (Modified from ucsfeye.net/mlavailRDratmodels.shtml)
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CHAPTER II
COMPARISON OF THE RETINA-PROSTHESIS
INTERFACE OF TWO SUBRETINAL PHOTOVOLTAIC
ARRAY DESIGNS IN A RAT MODEL OF
RETINITIS PIGMENTOSA

Introduction and Background
Many blinding eye diseases result from photoreceptor dysfunction and
degeneration. When this occurs, vision can be severely impaired and visual
perception may be lost completely. The most prevalent degenerative
photoreceptor diseases include AMD and RP. Together they affect approximately
1.9 million people in the United States and this number is expected to increase to
nearly three million within the next eight years as the baby boom generation
continues to age (Friedman et al., 2004). Currently, patients have few treatment
options and most therapies only delay disease progression. In AMD and RP,
although photoreceptors are lost, most of the other retinal cell classes remain;
including BCs, ACs and RGCs. The pathways through the retina initiate visual
image formation and send input to all higher visual centers in the brain. Thus,
many therapies aim to either replace the cells themselves or replace their
function. At present, there is no proven cellular therapy to replace lost
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photoreceptors. Other strategies include optogenetic expression of a bacterial
opsin in the remaining BCs and/or RGCs or replacement of photoreceptor
function with a prosthetic device.
Retinal neurons use changes in electrical potential to generate chemical
signals that transmit information across synapses, thus applied external electrical
current can stimulate neurons of the retina (Gebhard, J.W. 1952, Kurosawa
1954). As a potential treatment for the loss of photoreceptors, a retinal prosthetic
that responds to light and produces current should be capable of stimulating the
BC/RGC pathway. A highly proficient prosthetic device will have a high density of
electrodes; ideally it will emulate the ratio of electrode to BC similar to that found
between retinal photoreceptors and BCs. For optimal spatial coding, the
electrode size should be small but also provide sufficient current to stimulate a
small number of BCs over the extent of their dendritic arbor to theoretically
increase spatial resolution. Stimulation thresholds should be low and there
should be a linear range of current to response to emulate the graded response
of the photoreceptor itself. To be of use for a majority of patients, the
prosthetic/retina interface should be established regardless of disease
progression and should remain intact over a long time period. While devices such
as this have been made and tested previously, their design has produced limited
spatial discrimination. Towards the goal of a high-resolution prosthetic device, a
design has recently been produced to address these spatial limitations
(Mathieson et al., 2012). With this new design, current spread is theoretically
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more localized with the idea that it will enhance spatial acuity and the resolution
for an implanted patient.

Applied Electrical Stimulation
The ability of electrical stimulation to reliably elicit light perceptions
(phosphenes) in completely blind patients (Humayun et al., 1999) supports the
possibility that photoreceptor function can be replaced using implanted prosthetic
devices. Direct stimulation of the RGCs results in a 1:1 ratio of pulse to action
potential while stimulating the BCs results in a burst of RGC activity
(Eikenscheidt et al., 2012). This supports the theory that stimulating through BCs
allows the signal to be processed by the retinal circuit, potentially leading to a
better approximation of normal vision. Importantly, multiple studies have reported
that thresholds are the same when stimulating either through BCs or RGCs
directly (O’Hearn et al., 2006, Shah et al., 2006, Shyu et al., 2006). If thresholds
are the same regardless of the site of stimulation, then the better site should be
the one that best approximates the normal flow of the visual signal.

The Photovoltaic Effect
Prosthetic devices have multiple designs to create the electrical activity that
drives the postsynaptic cells. Most prosthesis designs utilize an external power
source to drive the device and deliver current to the retinal cells. An external
power supply is particularly useful for devices implanted in parts of the visual
system that cannot be directly stimulated by light, such as the optic nerve. When
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a prosthetic device is placed in the eye, it is possible to use light to generate
electric current directly from the device in a process known as the photovoltaic
effect. This is the same technology that solar panels use to convert sunlight into
energy to power our homes and cities. The process relies on the chemical
properties of semiconductor materials such as germanium, selenium, gallium,
telluride, and the most common material used, silicon. (www.eere.energy.gov).
Crystalline forms of these materials absorb light of sufficient energy and release
electrons bound in their crystalline lattice to a free conduction energy state.
When positive and negative diodes are paired, an electric field is introduced,
which generates current flow between them (pveducation.org). The current
generated can then be collected, as in solar cells, or in the prosthetic device to
stimulate the retina.

Prosthetic Devices and the Visual System
Multiple areas within the visual system are active areas of research for
prosthetic devices: the retina (Chow et al., 2004, DeMarco et al., 2007, Jensen
and Rizzo 2008), optic nerve (Veraart et al., 1998), and primary visual cortex
(Maynard et al., 1997) are all targets. Currently, there is a debate over the best
placement of a prosthetic device and how to stimulate the retina: trans-scleral,
suprachoroidal, subretinal or epiretinal (Rettay and Resatz, 2004; Figure 7).
The trans-scleral approach places the prosthesis outside of the eye on the
sclera. The current produced spreads through the sclera, choroid and RPE to
stimulate the retina. The clear advantage to this placement is a minimally
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invasive surgery with few risks such as infection or surgical damage to the eye or
retina. However, there are significant disadvantages to this approach. In
particular, much higher current is required to stimulate the retina compared to
intraocular approaches. The
high current levels may
adversely affect the sclera
and other surrounding
tissues. Further, the
resolution achieved is
significantly reduced due to
lateral current spread along
Figure 7. Intraocular implantation approaches for
retinal prosthetic devices. Modified from Rattay
and Resatz, 2004.

the outside of the eye.
The epiretinal approach

places the prosthesis within the vitreous cavity, close to the RGCs and their
nerve fiber layer (NFL). The advantage is that RGCs and their axons are directly
stimulated, which improves spatial resolution compared to a trans-scleral
approach. A significant disadvantage is that all current epiretinal designs have
external power supplies with wires that exit the eye. This creates a permanent
open surgical site, which increases the risk for complications, such as corneal
erosion and infections that have been reported in the Argus II trial (Humayun et
al., 2012). In addition, the wires must be configured to permit the eye and wire to
move freely. Improper placement increases stress on these wires and may result
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in catastrophic failure, requiring additional surgery and risk to the patient to
replace the damaged unit.
Subretinal and suprachoroidal approaches attempt to stimulate the retina
from the photoreceptor side. The advantage of stimulating from the INL side is
that it should stimulate cells in the INL to make use of the inherent circuitry within
the INL rather than bypassing it and stimulating RGCs directly (Cuenca et al.,
2004). Thus, the signal should be modulated before it is transmitted to the RGCs
and the rest of the visual system and should result in a better approximation of
normal vision. To date the interface between the prosthetic devices and the inner
retina has not been empirically tested in vivo. Whether the current is limited to
the inner retina or extends to directly stimulate the RGCs remains unknown. In a
subretinal approach, the prosthesis is inserted within the subretinal space with
the electrodes of the prosthesis in direct contact with the INL. In contrast, in a
suprachoroidal approach, the prosthesis is placed on top of the choroid and must
pass current through the choroid before reaching the INL. The possible
advantage over subretinal placement is the diffusion of nutrients from the choroid
may be improved. Although, the work of Pardue and colleagues indicates that the
absence of nutrient diffusion through a solid device over 8 weeks is not
detrimental to the underlying retinal morphology in RCS rats (another model of
RP), when implanted long term (27 weeks) in wild-type cats there was a
significant loss of photoreceptors directly beneath the device (Pardue et al.,
2001, Pardue et al., 2005). Whether function or the site of stimulation is altered
over time also has not been addressed. New designs are incorporating pores or
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channels within the device material to permit better nutrient diffusion. Whether
this will improve the outcome also has not been tested.

Neuroprotective effects of prosthetic devices and electrical stimulation
The direct benefits of prosthetic devices may be augmented by
neuroprotective effects. Pardue et al. (2005) showed an increased
electroretinogram (ERG) b-wave amplitude and photoreceptor preservation in
implanted RCS rats in the area of the implant. Demarco et al. (2007) reported a
trophic effect in RCS rats implanted with a prosthetic device even when the
device was an inactive type (non-current producing). Visual responses were
more robust within the area of the implant when compared to control RCS rats. In
contrast, the Mertk mouse, which has a similar mutation as the RCS rat, did not
show a neuroprotective effect from an implanted mPVA (Mocko et al., 2011). In
addition to effects of prosthetic devices, electrical stimulation has been reported
to protect axotomized RGCs (Morimoto et al., 2005), preserve photoreceptors (Ni
et al., 2009, Morimoto et al., 2012) and increase ERG amplitudes (Ni et al 2009).
The potential for neuroprotective effects has important implications concerning
when patients may optimally benefit from implantation of a prosthetic device.
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The mPVA (ASR) and bPVA Designs
The mPVA retinal prosthetic device was one of the earliest designs used
in human clinical studies (Figure 8; Optobionics, Inc., Chow et al., 2004, Chow et
al., 2010). In the RCS rat model of RP, DeMarco et al. (2007) were the first to
demonstrate the functional efficacy of the mPVA device in a degenerate retina by
recording prosthesis-evoked activity in the SC. While these were promising
results, the mPVA design is limited by two important factors. First, the solid wafer
design limits diffusion of
nutrients to the retina
directly under the device
(Chow et al., 2001) and
could impact the
preservation of inner
retina, exacerbating
degeneration. Second,
although the mPVA

Figure 8. mPVA type prosthesis. Left:
The 1 mm MPVA device. Middle:
Expanded view of the electrode array.
Right: Magnified view of a single
electrode in the array. Modified from
Mathieson et al., 2012.

incorporates hundreds of tiny electrodes (each 10μm) on its surface that have the
potential to generate high acuity vision, its single ground return electrode limits its
spatial resolution. With the return electrode located on the opposite side of the
electrodes, current must flow around the prosthesis. The current could potentially
stimulate any cell along the path it takes, degrading spatial resolution. A new
photovoltaic prosthetic design (Figure 9; Mathieson et al., 2012) attempts to
address both nutrient diffusion and current flow. First, the new design has 5 μm
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gaps around each electrode
that should increase nutrient
diffusion through the
prosthesis to the retina. The
design also includes a high
pixel-density array with
individual return electrodes
surrounding each pixel.
Figure 9. Scanning electron microscopy image of
the bPVA prosthesis current generating surface
with a magnified single pixel shown in the inset.
Modified from Wang et al., 2012.

Secondly, this design uses
a bipolar pulse with a
cathodic and anodic phase,

which has been shown to produce a more consistent response to repeated
stimulation than pulses of either type alone (Jensen and Rizzo, 2009). Prototype
designs have been produced in three
different pixel (electrode) sizes (70,
140, and 280 μm).
The intrinsic response
properties of silicon make near
infrared (NIR) light an ideal stimulus
in terms of the responsivity of the
array material to wavelength (Figure
10). Essentially, this means the
device will create more current for

Figure 10. Typical responsivity curve of
silicon based optical sensor. The blue
line represents the wavelength of the
near-infrared laser and the green line
represents the visible laser wavelength
of the PASCAL system. Modified from
www.thorlabs.com
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Figure 11. System
design for a patient.
The glasses contain a
camera and
projection system
connected to a small
pocket computer that
processes the image
before generating an
IR image to project
on the prosthesis.
(Mathieson et al.,
2012)

light in the NIR range as compared to visible light of the same intensity. The
design of the system for patient use includes a pair of glasses mounted with a
camera and projection system (Figure 11). The camera captures the visual scene
and sends this information to a small pocket computer to process the image. The
computer then sends a signal to the projector system contained within the
glasses. With software to track eye movements, the projector generates a NIR
image and transmits NIR light directly onto the prosthesis. In addition, this could
allow any residual visual processing in the patient’s retina to still be utilized with
visible light either from ambient light (possibly using a dichroic mirror) or visual
light projected from the system. Theoretically, the two signals should add
together to enhance visual perception.

Experimental Goal
The goal of these experiments was to characterize the retina-prosthesis
interface by showing the devices provide effective, repeatable and safe
stimulation of the retina that results in visual signals that are transmitted to a
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visual structure of the brain. The two prosthesis designs were compared to
determine if the bPVA presents a significant improvement over the mPVA design
in terms of spatial activation and threshold. In my experiments,
electrophysiological recordings were used to compare the mPVA and the bPVA
retinal prosthetic designs in terms of their ability to drive high resolution, low
threshold responses. As in DeMarco et al., (2007), my experiments used an
intact preparation to record responses in the SC as an indicator of the
prosthesis/retina interface, while stimulating the prosthetic device in situ.

Materials and Methods
Animals
All experiments were carried out with the approval of the Institutuional
Animal Care and Use Committee (IACUC) of the University of Louisville. The Tg
S334ter-3 rat was used for all experiments described in this chapter (Chapter II).
Homozygous Tg S334ter-3 rats were acquired from Dr. Matthew LaVail
(University of California, San Francisco). Homozygous Tg S334ter-3 rats were
generated on the albino Sprague-Dawley strain of rat. Because albinism affects
retinal function, homozygous Tg S334ter-3 rats were bred with Long Evans
pigmented rats to create hemizygous Tg S334ter-3 pigmented rats (one copy of
the transgene and two normal rhodopsin genes). Hemizygous Tg S334ter-3 rats
were the experimental animals and Long Evans rats served as normal controls
(Charles River Labs).
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Implant Surgery
Experimental animals are first anesthetized with an initial cocktail of
ketamine (85mg/kg) and xylazine (7.5 mg/kg). Once anesthetized, the pupil is
dilated with tropicamide and phenylephrine. A suture is placed in the upper eyelid
and traction applied to expose the superior portion of the eye. The eye is treated
with proparacaine as a topical anesthetic and a second suture is placed in the
superior conjunctiva near the limbus and the eye is rotated forward to expose the
superior conjunctiva. The conjunctiva is then dissected away to expose the
sclera. A 19-gauge vitrectomy knife is used to make a 1mm incision through the
sclera and the retina. Ten-minutes after a retinotomy, the retina will naturally
detach from the RPE at the retinotomy site, which creates a space to implant the
prosthesis. The prosthetic device is then manipulated carefully into the
retinotomy site and placement is verified with a fundus lens. Closure of the
retinotomy site has not been necessary because adverse effects (infection,
vitreous exudation, etc.) at the retinotomy site have not been oberved.
Two to four weeks after implantation, the surgical outcome was assessed
with fundus imaging, optical coherence tomography (OCT) and fluorescein
angiography (Figure 13). From the fundus image I determined the location of the
prosthesis in relation to the optic nerve. OCT images were used to determine the
general health of the retina. This technique generates perpendicular images
through the retina can help identify problems such as edema, gliosis, or other
trauma near the prosthetic device. The retinal vasculature is also an important
indicator of a successful surgery and the health of the retina. Fluorescein was
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used to illuminate vessels within the eye, after the dye is injected in the intraperitoneal cavity. Once in the vascular system, the dye is transported to the
retina and illuminates the retinal vasculature for assessment. A successful
surgery will show vasculature over the entire prosthesis as shown in Figure 12. If
the prosthesis was not subretinal or there were conspicuous complications within
the retina, the animal was not used for experimental purposes.

Prosthesis

Figure 12. Fundus image
(top), OCT image (bottom
left), and fluorescein
angiography (bottom right)
of mPVA implanted Tg
S334ter-3 rat. The prosthesis
is clearly visible in all three
measurements and the
retina is in contact with the
mPVA prosthesis based on
the OCT image.

Experimental Surgery
Animals were anesthetized with the same cocktail used for the implant
surgery. A diluted anesthesia cocktail (1:1 in ringer’s solution) was administered
throughout the duration of the experiment via a catheter inserted into the femoral
vein and an infusion pump. Once the catheter was in place, the animal was
immobilized in a stereotaxic. The skin on the dorsal surface of the skull was cut
down the midline and retracted to expose the skull surface. A micro-drill was then
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used to create a ~1.5 x 1.5 mm square craniotomy in the skull. The cortex was
then aspirated to expose the SC surface. Custom made lacquer coated tungsten
electrodes (0.25-2 MΩ) were used to record extra-cellular activity in either the SC
or optic nerve.

Electrophysiology
To record and assess prosthesis-evoked activity in the SC, a similar
design to DeMarco et al. (2007) was employed but incorporated the use of
targeted stimulation of the prosthetic devices. A modified PASCAL
photocoagulation laser (Topcon Medical Laser Systems) was used to direct a
laser directly to the prosthetic device. Normally, the PASCAL system is designed
to heat tissue within the retina to destroy portions of the retina or vasculature.
This can be used to treat retinal detachment, diabetic retinopathy, and the wet
form of age-related macular degeneration. In our application, the system
provides an infrared laser (905
nm) to stimulate the prosthetic
device or a green laser (535
nm) for visual stimulation,
alignment and to precisely
target the prosthesis. The laser
power has been reduced from
power levels that damage the
retina (~300 mW/mm2 for a

Figure 13. Spectral sensitivity of the
UV and M cones in rats. Jacobs et al.,
2001.
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single pulse) to innocuous levels for the retina (~2.4 to 19.1 mW/mm 2). A custom
LabView program (National Instruments Corporation) drives the laser and
modulates the pulse width (duration) and intensity. The laser spot size can be
adjusted to smaller or larger through the optics within the laser system itself or by
changing the fiber optic cable that transmits the laser beam. For both prosthetic
devices, the subretinal approach for implantation is utilized. In addition to the
advantages of NIR light to stimulate silicon, I can be certain that any evoked
activity with NIR light is generated through the prosthesis. Like mice, rats are
dichromats with a medium/long (M) cone and a UV-cone (or S cone), with peak
absorbance at 359 and 509 nm for the UV-cone and M-cone respectively (Figure
13). The M-cone spectral sensitivity is far below the 905 nm NIR light used for
this study. Therefore, stimulation with 905 nm NIR light will not stimulate either
cone type.
Multi-cellular responses were recorded from the SC using a single,
lacquer-insulated tungsten electrode. To map the spatial extent and retinotopy of
the prosthesis-evoked responses, the entire exposed dorsal surface of the SC
was recorded by stepping the electrode in 200 micron steps across 54 distinct
sites within the SC. The electrode depth was typically 150-400 microns,
consistent with the extent of the superficial layers of the SC. Trials consisted of
~20-25 stimulus presentations, with successful stimulation being defined as clear
responses in at least 50% of the trials.
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Data Analysis
All data were collected and processed in Spike2 (Cambridge Electronic
Designs, Cambridge, England). For statistical analyses, Prism 5.04 (Graphpad
Software, La Jolla, CA) was used. Normally distributed data were analyzed with
parametric statistics and a p-value<0.05 was considered significant. Unless
noted, the data were normally distributed.

Results
Direct stimulation of either type of prosthetic device yields short latency
responses that are transmitted to the SC via retinal synaptic input from BCs to
RGCs
The Tg S334ter-3 rat was used to assess the interface between both
types of PVA and the retina. Devices were implanted at either 35 or 75 days of
age and evaluation times post-surgery were grouped into 50-90 and 120-150
days. An example of a prosthesis evoked response to direct IR stimulation is
shown in Figure 14. Direct IR stimulation of the PVA produces prosthesis-evoked
responses in 80% (n = 21/25) of mPVA implanted and in 95% (n=20/21) of bPVA
implanted rats that were implanted successfully. This high success rate
represents an improvement over previous work with the same device in the RCS
RP model, where 64% (n=9/14) showed mPVA prosthesis-evoked responses. I
believe that this is due to the use of the new PASCAL stimulation system as it
combines the visualization of the device with direct presentation of the stimulus
onto the prosthesis (both visible and IR). In contrast, a full field IR stimulus was
used by Demarco et al. (2007).

28

Trial Number
Spikes/s

Figure 14. Raster plots
and post-stimulus
time histogram of
prosthesis-evoked
responses. The
stimulus is pulsed at
time 0 with 0.5
seconds shown before
and 0.75 s shown after
the pulse.

Time from stimulus (s)
In addition to its selectivity for IR stimuli, both mPVA and bPVA
prosthesis-evoked responses can be distinguished from visually-evoked
responses (with the same duration) by their significantly shorter time to peak
(Figure 15A; 53 and 43 ms vs. 176 ms). The responses evoked by the prosthetic
devices also had a significantly shorter duration than the visible stimulus of the
same pulse duration. The bPVA-evoked responses were slower to peak and had
a longer duration compared to mPVA-evoked responses (Figure 15B). A shorter
onset latency for PVA evoked responses is consistent with the idea that
responses are transferred through one less synapse (photoreceptor to BC)
compared to visually evoked responses. The integration time of light adapted
photoreceptors is ~ 40 ms (McNaughton, 1990), partially accounting for the
difference in time to peak. When added with the transmission time of
approximately 100 ms from BC transmission to RGC response (Baylor and
Fettiplace, 1977), these estimates suggest that the devices stimulate BCs
directly. To address this question, synaptic blockers were used to prevent
synaptic signaling within the retina. If the PVA-evoked responses are transmitted
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through the retinal circuitry, it would be expected that synaptic blockers would
eliminate PVA-evoked responses. If responses are present, it would indicate that
the PVA is acting directly on RGCs.

A.

B.

n=12

n=18

n=17

n=12

n=18

n=17

Figure 15. PVA-evoked responses respond with a shorter latency and duration
than visually-evoked responses in the same animals. A – A comparison of the
implant evoked responses (black trace) with the visually evoked response (blue trace)
from a bPVA (left) and an mPVA (right). In each case the stimulus duration was 4ms.
B – A quantitative comparison of two aspects of the evoked response shows that
implant evoked responses are significantly faster to peak and shorter duration
compared to visually evoked response. * p<0.05, **p<0.01, ***p<0.001

In four rats, an SC location with a robust prosthetic-evoked response was
selected for the synaptic blocker injection. While recording the spontaneous
activity, 2.5 μl of saline was injected into the vitreous chamber. Injections of
saline did not reduce the spontaneous activity or eliminate implant evoked
responses in the SC (Figure 16A, B, D). Five minutes after the saline injection,
an injection of 2.5 μl containing a cocktail of synaptic blockers (10 μM strychnine,
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10 μM picrotoxin, 50 μM TPMPA, 50 μM D-AP5, and 10 μM CNQX) was made.
When the blockers were present synaptic activity was largely eliminated and
bPVA-evoked responses were no longer elicited (Figure 16C, D). The effect of
the synaptic blockers was verified with a steady decline in spontaneous activity,
which was usually evident within 3-5 min after injection. These results indicate
that the prosthetic directly stimulates cells in the INL and not RGCs directly.
A

B

C

D

Figure 16. The bPVA response in the SC requires synaptic transmission of the signal
through the inner retinal circuit. A. Representative averaged response and raster plot
of bPVA evoked response. B. Injection of 2.5 µl of saline did not significantly alter the
bPVA-evoked response or spontaneous activity in the same animal. C. Injection of the
synaptic blocker cocktail (2.5 µl total volume) eliminated all bPVA-evoked responses.
D. Average normalized peak response across four animals.

Given that the responses are network dependent, the additional reduction in time
to peak of the IR-evoked responses is likely due to direct depolarization of the
BC, thereby bypassing the PR-BC signalling cascade. The light-evoked time to
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peak response in WT rat BCs is ~80 ms for ON BCs, ~100ms for OFF BCs, and
~175ms in rod BCs (Euler and Masland, 2000). In normal signalling, glutamate
binding opens iGluRs directly in OFF BCs while in ON BCs, a reduction in
glutamate binding inhibits a G-protein coupled cascade that normally closes the
TRPM1 channel. These signaling processes act to depolarize BCs and open
voltage gated calcium channels at the BC axon terminals. The increase in intracellular calcium causes the release of vesicles from the axon terminal. These
channel gated and G-protein related processes in the BC dendrites are likely to
be bypassed when stimulated by a PVA. The latency, therefore, would be limited
to the time for calcium entry into the BC terminals, vessicular release,
neurotransmitter diffusion across the BC to RGC synapse, and depolarization of
the RGC.
In addition, Sekirnjak et al. (2008) reported direct activation of RGCs in
monkey retina resulted in sub-millisecond latency to response. In no experiment
did I record responses in the SC with a latency that was less than 35
milliseconds. Taken together, the above data strongly support my hypothesis that
the bPVA devices stimulate the retinal network rather than RGCs directly.

Direct stimulation of the prosthetic device yields responses in a location generally
matched to the position of the implant in the retina.
Since the SC forms a retinotopic map, the IR-evoked responses should
correlate with the location of the device in the eye. Without a predictable
relationship between the location of the prosthetic and the area of the retina
stimulated, spatial information would not be reliably relayed to the patient. To
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address whether or not the predicted location of stimulation matched the
observed location of stimulation, fundus images for each implanted rat were
taken, which included the optic nerve head (ONH) and the device. The location of
the device relative to the ONH along the vertical and horizontal meridians were
computed and compared to the sites of evoked activity on the SC retinotopic
map. Figure 17 shows representative images of the fundus of two rats implanted
with an mPVA (top) and a bPVA (bottom). The corresponding PVA evoked
responses are plotted on the right as a heat map of the dorsal surface of the SC.
Responsive areas appear as colors, where red represents the strongest
excitatory responses and blue the weakest responses. Black areas indicate
locations in the SC where prosthetic evoked responses were not elicited. I
compared the location of PVA evoked responses recorded in the SC
to their expected location based on implant placement in the eye. The fundus
image was used to compute an estimate of the expected location of PVA
influence in the SC. To do this, I first measure the distance to the center of the
device from the center of the optic nerve head along the vertical (superiorinferior) and horizontal (temporal-nasal) axes (Figure 18A). These two distances
are converted to visual degrees where 59 μm subtends 1o of visual angle in the
rat eye (Siminoff et al., 1966). These estimates are then compared to the location
of the peak PVA-evoked responses in the SC using an image adapted from
Siminoff et al. (1966, Figure 18B). Each line on the SC map in Figure 18B
represents 10 degrees and the optic nerve has a defined position. Using the
fundus image estimates, the difference between the two locations was calculated
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along each axis. For reference, the bPVA device is 1.2x0.8 mm which
corresponds to 20x13.5 degrees of visual angle.

mPVA

Nasal

Inferior

Peak IR Response

Superior

Temporal
ONH

0.5 mm

bPVA

0.5 mm

Figure 17. Representative
fundus images and
corresponding SC activity
maps. The top fundus image
and map show a localized
region with prosthesis-evoked
responses. Stronger
responses are in red and
weaker responses in blue.
Black represents
unresponsive locations. ONH
= optic nerve head.

Unresponsive (Black)
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A

B

Figure 18. A. Fundus image showing the size of the implant in visual degrees and the
distance from the optic nerve along both the S-I and T-N axis. B. For the animal shown in
A, the deviation of the SC recorded activity from the predicted location is plotted on the
dorsal surface of the SC. Each line on the SC map represents ten visual degrees.

Figure 19A plots the predicted location of the PVA as a function of the location of
its actual evoked activity. Each arrow represents one animal and the length of the
arrow represents the change between predicted location (blue dot) and the actual
center of the recorded activity in the SC (red arrow head). The rat retina covers
approximately 140 degrees along the T-N axis and 130 degress across the S-I
axis (Siminoff et al 1966). Figure 19B plots a summary of the deviations from the
predicted location for all rats. On this graph, a perfect match between predicted
and actual is represented by the green circle at the origin (0,0). Given the size of
the retinal representation, the differences I observed are fairly restricted.
However, there is a trend, in 22 out of 23 rats the predicted location is superior
to the actual area of activity. Additionally, in 16 out of 23 rats the predicted
location is nasal to the actual area of activity. Given the consistency of the
direction of difference, it most likely indicates a consistent error in one of our
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estimates of location on the SC surface due to errors of electrode placement
(discussed below) or differences in the visual map with the estimates of Siminoff
et al., 1966. In addition, there is the possibility that the implant could have
changed location in the time between imaging the fundus and
electrophysiological assessment (2-4 weeks).
A.

B.

Figure 19. A. SC representation of each animal’s predicted vs. actual location
of PVA influence. B. The deviation from the predicted location. Perfect
correlation between the predicted and actual area of PVA influence in the SC
would be at the origin (0,0).

Measurement errors were introduced due to the way I estimated the
location of the device based the fundus image and also due to the recording
protocol. The device itself covers up to 20o, but the fundus measurement was
taken to the center of the device. This introduces an error of up to 10o due to the
size of the device as the recorded activity was not necessarily from the center of
the device. Current spread at the edges of the prosthesis also makes the device
functionally slightly larger than its physical size by ~200 μm (3.5 o) at each edge
(unpublished obervations by our collaborators). Our estimates of SC location
36

may contribute as a result of anatomic variation. Blood vessels on the surface of
the SC are used as a reference for placement of the first recording site, but there
can be substantial anatomical variation from animal to animal. When all sources
of error are considered, I compute a potential error of 30o, 18 out of 23 locations
fall within this predicted error range. Data points outside of this margin of error
may indicate an implant interface directly with RGCs and their axons crossing
under the PVA. This would create large deviations from the predicted location.
Alternatiely, devices may have physically shifted more in these animals over
time. Because there were so few of these animals and the calculations were
made after experiments, I did not test the idea that RGCs were directly
stimulated in these animals.

Implantation age and duration have no significant effect on thresholds for mPVA
evoked responses
The threshold for stimulation is a concern with implant devices, as too
much current can cause damage to both the retina and the device. Further, there
could be differences in the interface between the implant and the degenerating
retina as photoreceptor death proceeds. To examine these questions, I
compared thresholds in two groups of Tg S334ter-3 rats implanted at different
stages of degeneration, ~P35 and ~P75. I also varied the time between
implantation and evaluation in both implantation age groups: 120-150 days post
implantation. At P35 there are 3-5 rows of nuclei left in the ONL while P75
animals only have 1-2 rows of nuclei remaining, responding exclusively to
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photopic stimuli. Figure 20 compares the threshold responses across
implantation age (A) and duration (B). The data show that neither implantation
age nor duration have a significant effect on threshold, consistent with data
reported by Chan et al (2011).
A

B

Figure 20. The figures plot the minimum intensity required to elicit a response
at a particular pulse duration. A. Implantation age had no effect on thresholds
for stimulation. B. Implantation duration also did not affect stimulation
thresholds. Note all thresholds are at least 1.5 log units below safety limits
(dashed line) for the retina.

Threshold for stimulation is not different across pixel sizes in bPVA devices but
bPVA devices have a significantly higher threshold than mPVA devices.
Theoretically, reducing pixel size and increasing density will increase
visual spatial resolution. However, pixel size affects current density which can
affect lateral current spread. To compare the effect of pixel size on threshold,
three groups of animals were implanted with small (70 μm), medium (140 μm), or
large (280 μm) pixel bPVA devices. Figure 21 compares the threshold responses
across pixel size within bPVA devices (A) and between mPVA and bPVA devices
(B). The data show that pixel size did not significantly influence threshold for
bPVA devices. Figure 21A shows the comparison across pixel size with all
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having similar thresholds. When compared to mPVA devices however, bPVAs
have a consistently higher threshold. This is probably a function of their smaller
current spread, which is more spatially limited than the bPVA device. The current
generated by smaller electrodes will not spread as far, requiring either a closer
interface between the electrode and the tissue to be stimulated or for the
electrode to produce more current (Palanker et al., 2005). Thus, higher threshold
in bPVAs is consistent with expectations. It is important to note that all thresholds
are well below the defined safetly limit for these devices in the retina.

Figure 21. Device thresholds are well below the safety limits. A. The intensityduration plot comparing bPVA pixel sizes. Medium and large pixels were not
significantly different from one another. B. Comparison between small bPVA,
combined medium and large bPVA, and mPVA device thresholds. mPVA thresholds
were similar to the medium/large bPVA devices but small bPVA devices had a
significantly higher threshold than the mPVA device thresholds. (Kruskal-Wallis).
***P<0.001, ****p<0.0001

PVA-evoked responses have a linear range as a function of pulse duration
The interaction between the retina and a prosthetic device is certain to
shape the perception for a patient. In the intact retina, the output of the
photoreceptor is proportional to the intensity of the light within a given adaptation
range. Similarly, it is ideal if the amount of current produced by the implant is
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proportional to the intensity of the IR stimulus. In this way, larger portions of the
retina or cells with higher threshold may be recruited when the device is driven
harder to increase the current output of the device. In addition, the response
limits of the retina are important to quantify in order to keep the stimulus intensity
as low as possible (to prevent damage to the tissue) while eliciting consistent
responses.

n=17
n=7

**
****

****
***
****
****

Figure 22. Normalized response as a function of pulse duration. Compared to
the 10 ms response, both mPVA and bPVA devices show a linear range
between 0.25 and 2 ms. Beyond 2 ms, the response does not significantly
increase further. **p<0.01, ***p<0.001, ****p<0.0001

To determine if the peak SC response changes as a function of pulse
duration, I recorded from the SC while modulating the pulse duration. Figure 22
plots these data and demonstrates a linear relationship between response and
pulse duration between 0.25 and 2 ms with saturation at durations above 2 ms.
This relationship was the same for both bPBA and mPVA devices and there was
no significant difference between device types.
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bPVA devices provide focal activation of the retina that is not seen with mPVA
devices
At present there are devices that are being tested in human RP patients
(Humayun et al., 2010). These implants have a limited number of electrodes with
relatively wide spacing. While preliminary reports are promising, most patients
can only use the device for simple pattern vision or luminance levels. However,
the ultimate goal is to provide high spatial and temporal resolution vision to
patients that have lost photoreceptors. To test the hypothesis that the bPVA
design should activate the retina in a focal manner with increased spatial
resolution over the mPVA, I measured the spatial resolution of mPVA (n=12) and
bPVA (n=14) devices in implanted animals. An
SC site with a robust PVA-evoked response was
selected and the response at this site was
recorded as a small diameter spot stimulus (0.5
mm) was systematically moved to one of five
sites on the PVA. Figure 23 depicts the regions
stimulated under this paradigm. Comparisons
were made with the IR stimulus located in either
the center or in one of four quadrants of the PVA.
Figure 23. Diagram
showing the five different
stimulus locations for each
device type. The larger
circle represents an mPVA
and the entire rectangle a
bPVA.

The comparison was made to determine if the
response would increase or decrease depending
on what region of the device was stimulated.
Since the SC is topographically organized,
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stimulating the device in different regions should shift the area of response in the
SC to match the region of the retina that is stimulated. In this way, recording at
one SC site while moving the IR stimulus should reduce or increase the reponse
recorded in the SC. If the response does not change, the entire device is
stimulating regions of the retina that are larger than the stimulus. In this scenario,
the entire device is functionally a single pixel, rendering the electrode array
ineffective for any spatial resolution. Figure 24 plots representative

Figure 24. A. Histogram showing an example of the unmodulated
response typical of mPVA devices. B. Example of a significantly
modulated response from a bPVA implanted animal.

responses for an mPVA (A) and a bPVA (B) device. The responses evoked by
spots across mPVA devices were similar in 14/17 animals (Figure 25), indicating
little or no spatial resolution. In contrast, bPVA devices showed significant
response change as a function of spot location in 22/23 animals, where the
response at each region was compared to the largest response region across the
device. I believe that the best explanation for response modulation in the 3/17
mPVA is a poor interface between the prosthesis and the retina in one quadrant
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of the device. In these devices, the
quadrant with smaller responses may not
have been as closely juxtaposed to the
retina, resulitng in one region with a
significanly smaller response. These
results strongly support the idea that
Figure 25. Overall, only 1 bPVA
device did not show some
modulation while only 3 of 17
mPVA devices showed any
modulation when moving the
stimulus location across the face
of the PVA.

current generated by bPVA devices is
able to flow locally because of the
individual return electrodes. This also
strongly supports the bPVA design as a
significant improvement over older prosthetics.

Discussion
In comparing the mPVA and bPVA devices, my results demonstrate that
the bPVA design is a significant improvement in prosthetic device design. The
primary improvement is its superior spatial localization, while continuing to
achieve low thresholds for activation that are far below established safety limits
for the retina. The high integration success with the bPVA devices indicates a
better interaction between the device and the retina than the older mPVA device.
This is likely due to the targeted stimulus but may also result from the increased
flexibility of the bPVA design. Jensen and Rizzo (2009) concluded that a biphasic
pulse was the most consistent stimulus to use in the rd1 mouse model of RP and
my results with a higher success rate using bPVA devices support their
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conclusion. It was very evident that surgical implantation technique is paramount
to a successful interface of the device with the retina. All animals without a clear
interface between the device and the retina (OCT images) had no prosthesis
evoked responses.
As manufacturing technology becomes more advanced, the size of the
electrodes will undoubtedly decrese to theoretically provide increasingly focal
stimulation of the retina. While it is important to increase the resolution of the
devices and the perceived image, the safety of the retina must be considered as
well. There was a trend for an increase in threshold in the smallest size pixel in
the bPVA devices (70 μm). In addition, there was a significant increase in
thresholds for bPVA devices when compared to mPVA devices. While still far
below safety limits, the challenge for new devices in the future will be a balance
between the size of the electrodes and approaching safety limits. Any increase in
risk to the patient or to the lifetime of the device must be carefully considered
when attempting to improve the design of prosthetic devices.
It should be noted that other approaches also are being actively explored
for the replacement of degenerated photoreceptors. For example, of great
potential for restoration of vision for patients with degenerative disease is the
transplantation of stem or other progenitor cells into the retina (Schmeer et al.,
2012). The current state of this potential treatment is far behind retinal
prosthetics. Early clinical trials using stem cells are currently under way though
some trials ended prematurely due to safety concerns. In contrast, the FDA
recently approved the first prosthetic device for use in humans. Second Sight
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Medical Products Inc. received approval for general use of their 60 electrode
Argus II device in end stage RP patients in the US. Additionally, the state of the
retina for stem cells or transplants may preclude patients with severely
degenerated retinas. It has been shown that there are significant morphological
and structural changes that take place in advanced stage human RP patients
and animal models (Marc and Jones, 2003). In addition, the expression of
mGluR6 receptors in the BCs has been shown to decline in multiple models of
RP, including rd1 and 10 mice (Stasheff 2008, Puthussary et al., 2009;
respectively) and RCS rat (Pu et al., 2006) while the expression of iGluR on OFF
BCs is stable even after the loss of all visual signaling. If the retina can no longer
respond to glutamate signaling, implantation of photoreceptors would be
ineffective at these stages of degeneration the retina, even if synapses form
between the stem cells and BCs. If this loss of glutamate receptors is evident in
human RP patients as well, the best treatment option may be retinal prosthetic
devices. In addition, embryonic stem cells require immune-suppressive therapy
for the life of the patient, something that is not required with prosthetic devices.
This is not a trivial matter as major health complications can arise when the
immune system is suppressed.
The wide-spread use of retinal prosthetic devices is still in the beginning
stages and many questions remain unanswered. Will retinal adaptation to
electrical stimulation result in higher thresholds for activation over time? There is
evidence for short-term adaptation on the order of seconds (Freeman and Fried,
2011) but long-term stability of thresholds in humans has not been definitively
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established. In many cases, the first response to PVA-stimulation did appear to
be larger but this was not quantified. This analysis will be addressed in the future.
There is debate about what the most physiologically relevant stimulus is to
the retina. It has been shown that rabbit RGCs can follow pulse trains up to 600
Hz when stimulated directly using tungsten electrodes (Cai et al., 2011) but
normal human frequency limits are in the range of 45 Hz. Does the stimulus have
to transmit signals that are close to what is processed normally or will plasticity
within the visual system enable it to adapt to this new information and interpret it
as normal (or potentially supernormal) perceptions? Can a stimulation
configuration be found to differentially stimulate specific cell sub-types to
generate both ON and OFF signals? BCs are the point at which the ON and OFF
pathways diverge, so stimulating all BC types at the same time may result in
conflicting signals. On the other hand, there is evidence in the literature that
patients with complete congenital stationary night blindness, where the retina
lacks signaling through the ON pathway, have relatively normal day vision
(Bijveld et al., 2013). Therefore, it is possible that the device does not require
dual pathway signaling to provide normal vision.
Regardless of the answers to these questions, there is no doubt that
retinal prosthetic devices integrate with the degenerate retina and generate
signals that can be detected outside of the retina and can be used to represent
some properties of the visual environment, in patients with photoreceptor
degeneration. While the current visual acuity achieved with prosthetic devices in
my studies as well as in work with human patients may be low (20/560 Zrenner et
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al., 2012 and 20/1260 with Argus II system, Humayun et al., 2012), this can still
represent a life changing treatment. Many patients involved in clinical trials were
late stage patients with little more than light or dark perception if any perception
at all. The potential of these devices to provide independence for a profoundly
blind patient cannot be understated. To have form, contrast, and/or depth
perception again may allow them to navigate a room without bumping into
objects, cross the street safely, or cook a meal easily; all things those with
normal vision take for granted.

47

CHAPTER III
FUNCTIONAL ASSESSMENT OF TWO MODELS OF
RETINITIS PIGMENTOSA INDICATE A PREFERENTIAL
LOSS OF THE ON PATHWAY DURING THE
DEGENERATIVE PROCESS

Introduction
In many cases, patients with degenerative diseases of the retina do not
present with symptoms until very late in the progression of the disease. Often the
loss of vision is what drives patients to see a physician. Unfortunately, during the
degenerative process within the photoreceptor layer, the rest of the retina is not
static. Morphologically, there are numerous reports that show anatomical
reorganization, but changes in function at the level of the RGCs have not been
well studied. To better understand what treatments may be most effective, a
description of these changes is needed. If early functional changes are found,
this could facilitate early therapeutic intervention and may lead to new early
screening procedures, all of which may lead to a better prognosis for patients
with degenerative diseases.
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Reactive Changes During Degeneration
Morphologic changes that occur during the degenerative process have
been described previously. In rat and mouse models of RP, a combination of glial
migration, vascular and RPE invasion, receptor expression changes, aberrant
connections, and other changes have been described (Marc and Jones, 2003,
Cuenca et al., 2004). Changes within the INL include neurite sprouting in
horizontal cells, retraction of BC dendrites, and decreased mGluR6 staining
(Strettoi et al., 2002). Aberrant connections form between rod BCs and cones in
late stages of degeneration though it is not known if the synapses are functional
(Marc and Jones, 2003, Cuenca et al., 2004).
In addition to structural changes, some morphological and functional
changes have been reported. In the rd1 mouse, mGluR6 receptor expression on
the BC dendritic tips is lost early in the degenerative process, while iGluR
receptors (the OFF pathway) have been reported to persist and respond in vitro
to AMPA/Kainate (iGluR agonists) puffs long after photoreceptors are lost
(Stasheff, 2008). Functionally, the loss of RGCs with ON responses and the
retention of RGCs with OFF responses have also been reported in the rd10
mouse (Puthessary et al., 2009, Stasheff et al., 2011) and the RCS rat (Pu et al
2006). The question remains, however, if this is something inherent to the
degenerative process in general or if it is a result of a subset of specific
mutations. The three examples listed above represent a mutation in rod
photoreceptors (Pde6 gene) for the rd1 and rd10 mice and a mutation in the RPE
(Mertk gene) for the RCS rat, suggesting this may be common to RP. However,
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Sekirnjak et al. (2011) reported that there was no differential loss of ON vs. OFF
responses in the Tg P23H-1 rat. They did find, however, that in the spontaneous
firing rate of their OFF RGCs was elevated, while ON RGC firing rate declined. In
both types of RGCs, receptive field size reduced with age, indicating a reduction
in excitatory input. Importantly though, all RGCs were responsive to direct
electrical stimulation even after light stimuli could no longer evoke a response
(Sekirnjak et al 2009).

Increased Spontaneous Activity and Rhythmic Bursting
Many models of retinal dysfunction exhibit characteristic bursting in their
spontaneous activity that is rhythmic. In the rd1 mouse, bursts of activity at ~10
Hz were found in both ON and OFF RGCs, but the morphology and dendritic
stratification of these RGCs remained unaltered (Margolis et al 2008). This
characteristic bursting activity has been described in other retinal mutants as
well, including the nob mouse (Demas et al., 2006), Tg P23H-1 rat (Sekirnjak et
al., 2009), and RCS rat (Sauve et al., 2001) among others. This suggests there
are common functional changes within the retina when normal signaling
pathways to RGCs are lost. If a common mechanism exists for changes in
spontaneous activity, it is possible that there are other common functional
changes across retinal degeneration models as well.
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Experimental Goal
The goal of these experiments was to describe some of the functional
changes that are associated with the degenerative process. Responses were
recorded from the SC in Tg rats and compared to age matched WT animals.
Most previous research has focused on morphological changes within the retina
but the functional changes have been explored to a lesser extent. To replace lost
photoreceptors, either functionally or with cellular transplants, the remaining
retina must be able to transmit signals. A description of functional changes will
help guide future research and help determine the limits of proposed treatments.
An in vivo preparation was used to determine what signals are transmitted to the
SC from the retina as photoreceptors are lost.

Materials and Methods
Animals
Three rat strains were used for all experiments. The Long Evans strain
(Charles River Labs) was used as the control for all experiments and exhibits
normal retinal function and morphology. Homozygous Tg P23H-1 and Tg
S334ter-3 rats were acquired from Dr. Matthew LaVail at the University of
California, San Francisco, CA. Homozygous animals for both models are albino
as the Sprague-Dawley rat was used as the background strain. In order to
circumvent effects of albinism, homozygous Tg animals were bred with Long
Evans rats to create hemizygous Tg pigmented animals with one copy of the
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transgene and two normal rat rhodopsin genes. Hemizygous Tg animals are
used in all experiments.

In Vivo Experimental Surgery
The animal is first anesthetized with a cocktail of anesthesia consisting of
ketamine and xylazine administered at a dose of ~105 and 7.5 mg/kg
respectively. Once deeply anesthetized, a custom catheter is surgically placed in
the femoral vein to administer a booster cocktail at half the original concentration.
The catheter is attached to a syringe pump to keep the animal at a constant
plane of anesthesia for the duration of the experiment. Once the catheter is in
place, the animal is placed in a stereotaxis (David Kopf Instruments) to
immobilize the head. The skin over the skull is retracted by making a 1 inch
incision down the midline. Any connective tissue is teased away from the skull to
expose the sutures. Using the labdoidal, coronal and sagittal sutures as
landmarks, a micro drill (Fine Science Tools, Heidelberg, Germany) is used to
make an approximately 1x1 cm opening in the skull. The dura is removed
carefully and once exposed, the surface of the brain is vacuum aspirated to
expose the surface of the SC.
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In Vivo Electrophysiology
Once the surface of the SC is exposed, a custom made lacquer coated
tungsten electrode (0.25-2 MΩ) is used to record extra-cellular activity in the SC.
The margins of the SC are estimated based on large blood vessels that border
the edges. The electrode is positioned over the first SC site using a set of
manipulators (David Kopf Instruments) along the X and Y axis. Once in place, a
hydraulic microdrive (David Kopf Instruments) is used to lower the electrode to
the proper depth at a rate of 25 µm per second. The best recorded responses
were at a depth range between 150 and 400 microns. A clear bursting activity
was heard if the electrode was lowered beyond this range, indicating the
electrode had passed through the superficial visual layers of the SC. Data was
sampled at 54 sites encompassing the entire exposed surface of the SC. The
space between two adjacent sites is
approximately 200 µm (Figure 26).
3
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Full field stimulation with a peak
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room. The stimulus intensity, duration
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(2s), and inter-stimulus interval (10s)
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was controlled using custom programs

200 µm

in LabView (National Instruments,
Figure 26. The 54 sites
sampled across the dorsal
surface of the SC.

Austin, TX). Signals were amplified
through an XCell-3 Microelectrode
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Amplifier (FHC, Bowdoin, ME) and sampled at 10 KHz using a Power1401 data
acquisition unit (Cambridge Electronic Design, Cambridge, England). Data was
collected and stored on a computer running Spike2 software (Cambridge
Electronic Design, Cambridge, England).

In Vivo Data Analysis
Data was later analyzed offline using custom scripts in Spike2. Briefly, a
threshold was set at 3.5 standard deviations above the average noise
(spontaneous activity) levels and this was used to define the response (or lack
of). The raw data was converted to a wave form based on the rate histogram
(Figure 27). This wave form was then averaged across the ~20 trials and then
analyzed for response parameters, including response area, amplitude, time to
peak, and response duration. This was further broken down to the ON response
and OFF response as the long 2s stimulus allows the two responses to be clearly
distinguished. Once the response parameters were quantified, statistical analysis
was performed using Prism 6 (GraphPad, Inc., LaJolla, CA).
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A.

Figure 27. A. Example raw SC response
trace. B. PSTH generated from the raw trace.
C. Wave form converted from the PSTH in B.
The response is defined as the time at which
the trace crosses threshold (blue line in C.)
to the time it dips back below threshold.
Threshold is defined as 3.5 standard
deviations above the spontaneous activity.
The red bar is the time the stimulus is on
(2s).
ON Response

B.

OFF Response

C.

In Vitro Preparation
For multi-electrode array (MEA) recordings, animals were dark adapted for
at least 1 hour prior to recording. Using infra-red goggles, animals were
anesthetized with the same cocktail of ketamine and xylazine. Once deeply
anesthetized, the animal was sacrificed via thoracotomy and the eyes
enucleated. Under dim red light, the cornea and lens were removed and the
retina dissected from the eye cup. The retina was then laid RGC side up and
rinsed with oxygenated bicarbonate buffered Ringer’s solution. A mixture of
collagenase and hyaluronidase was then placed on the retina for 15 minutes to
remove the vitreous. The retina was then rinsed three times, any remaining
vitreous removed with fine forceps, and then quartered. One quarter was placed
photoreceptor side against a culture membrane and then transferred to the
recording chamber where it was placed RGC side against the electrodes. A
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platinum ring was then placed on top of the membrane but not the retina, so not
to occlude any visual stimulus from the retina.

In Vitro Electrophysiology
The MEA (Multi-Channel Systems, Reutlingen, Germany) consists of a
glass chamber with 60 platinum-iridium electrodes lining the bottom of the
chamber. Each electrode is 30 µm in diameter and the inter-electrode distance is
200 µm. Each electrode records extracellular spiking activity from the RGCs.
Data is sampled at 10 kHz and recorded with a MEA1060 system from MultiChannel Systems. The same full-field stimulus (470 nm, duration, intensity, isi,
etc.) used for the in vivo experiments was used for these experiments. The data
was collected using MC_Rack software (Multi-Channel Systems), band pass
filtered between 80 and 3000 Hz and spikes were sorted into individual units
manually using Offline Sorter (Plexon, Inc., Dallas, TX). Individual units with an
amplitude less than ~40 µV were not used. Data was then analyzed using
Neuroexplorer (Plexon, Inc., Dallas, TX).

ON-OFF Index
To compare the ON-OFF ratio between groups, an ON-OFF index value
was calculated. This was done to normalize the data for comparison and ensure
that the absolute values were not artificially creating differences between groups
due to an experimental setup difference over time as this study was dependent
on large age differences between animals, and hence long times between
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recording different groups. This value is calculated as follows; the OFF
component is subtracted from the ON component and this is then divided by the
sum of the same ON and OFF component:
ON-OFF
ON+OFF

This results in a possible range from 1 to -1, where 1 represents a completely ON
dominated response, -1 represents a completely OFF dominated response and 0
would be equal responses between the two components.

Results
As photoreceptors are lost, there is a shift from ON to OFF dominated SC
responses in Tg P23H-1 rats
I recorded the visual responses in the SC of control rats as they aged (50
to 300 days). In the SC, responses to a 2s stimulus evoked a response at both
light onset and at light offset. In control rats, SC responses show both an ON and
OFF response to visual stimuli with a slightly larger ON response on average.
This response profile does not change with age in WT rats. As no changes were
seen in WT rats, in all of the comparisons with Tg rats, WT data were combined
into one control group.
Consistent with morphological observations (Kolomiets et al., 2010), the
cone-driven visual responses in hemizygous Tg P23H-1 RGCs declined with age
up to ~P550 (Sekirnjak et al., 2009). My data also show visually evoked
responses in the SC through P300 in hemizygous Tg P23H-1 rats, my oldest
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group evaluated. In addition to the overall loss of visual function, I found a
surprising change in the balance between the ON-OFF responses in the SC in
Tg P23H-1 rats when compared to WT. In Tg P23H-1 animals up to ~P90, SC
responses are balanced between ON and OFF and are relatively similar to WT.
From ~P120 the Tg P23H-1 responses in the SC shifted towards OFF dominated
and the shift became more pronounced with age and progression of
photoreceptor degeneration (Figure 28). This finding had not been previously
reported in this RP model; in fact a lack of change has been reported (Sekirnjak
et al., 2009). At approximately P300, where the total ON response has decline to
~25% of WT, Tg P23H-1 SC responses are strongly OFF-dominated and the
OFF response has increased to ~250% over the WT OFF response (Figure 29).
The total response depends on both response amplitude and duration, and
changes in either of these parameters could cause this overall response change.
I examined both of these parameters and Figure 30 plots the changes in duration
and amplitude of the SC ON and OFF responses as a function of age.
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Figure 4

Figure 28.
A: Typical visually-evoked response in the SC of a WT rat.
B: Typical visually evoked response in the SC of P300 Tg P23H-1 rats. The
white bar beneath each PSTH represents the duration of the visible
stimulus. There is a large On response and a smaller Off response in WT
SC. In contrast, the response in P300 Tg P23H rats shows a strongly Offdominated response that has developed with age.

Figure 29. Comparison of the On and Off total SC response in Tg P23H-1 rats
as they age compared to WT rats. No age related changes were seen in WT
rats, therefore all WT animals were grouped for this comparison. *p <0.05,
**p<0.01, ***p<0.001, ****p<0.0001. WT n=13, Tg P23H-1 n=6 for each group
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A.

B.

Figure 30. A. ON and OFF response duration in WT vs. Tg P23H-1 rats as
they age. B. ON and OFF response amplitude in WT vs. Tg P23H-1 rats as
they age. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. WT n=13 Tg P23H-1 n=6
per group

The results suggest that the loss of the ON response is due mainly to a loss of
response duration. In contrast, the increase in the OFF response is driven by an
increase in response amplitude. This indicates that the ON pathway input to the
SC initially becomes more transient and then loses overall excitatory input or
there is a change in the SC circuitry as a result of a loss of excitatory input from
the retina. The OFF response peak amplitude significantly increases, which is
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most likely to result from a loss of tonic inhibition from the declining ON pathway
either at the level of the retinal input or within the SC circuit.

OFF dominated SC responses arise early and do not change in Tg S334ter-3
rats
When compared to the Tg P23H-1 rat, the Tg S334ter-3 mutation results
in a much faster degeneration of photoreceptors. This includes a decline in both
rod and cone driven responses in the SC. The functional consequences of this
degeneration were equally rapid. In Tg S334ter-3 rats, SC responses were
already OFF dominated at the youngest age I recorded, P25 (Figure 31; Note: it
is very difficult to record from rats younger than P25 in vivo). This difference
between the two models is clearly evident with the aggressive degeneration
present in the Tg S334ter-3 model.

n=2
n=13

n=13

n=3

n=2

n=3

n=5

n=5

Figure 31. Comparison of the ON and OFF total SC response in Tg
S334ter-3 rats. In contrast to the Tg P23H-1 rats, there were no age related
changes in the Tg S334ter-3 rats. *p<0.05, **p<0.01, ***p<0.001,
****P<0.0001

Similar to previous publications, I found that by ~P180, all visual responses in the
SC are lost. There also were no significant changes in the ON or OFF response
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characteristics as the animals aged in contrast to Tg P23H-1 rats. While the OFF
response increased in Tg P23H-1 rats, this was not the case in Tg S334ter-3
rats. The OFF response was not significantly different from WT in Tg S334ter-3
rats at any age. Combined with the lack of change in the ON pathway with age,
this may indicate a sort of functional steady state within the retina until all visual
responses are lost. In addition, this may mean only neurons within the ON
pathway need to be targeted for treatment, while both the ON and OFF pathway
in Tg P23H-1 rats may need to be treated to address their respective changes.
Figure 32 plots the ON-OFF index values for the Tg S334ter-3 groups. When
compared to the profile of the Tg P23H-1, Tg S334ter-3 rats have a similar profile
to the oldest Tg P23H-1 rats with very OFF dominated responses in all age
groups.

Figure 32. The ONOFF index for Tg
S334ter-3 rats shows
strongly OFF
dominated
responses, similar to
P33 Tg P23H-1 rats
but does not change
as a function of age.
****p<0.0001
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The loss of ON responses is not specific to the SC as Tg P23H-1 rat retina
shows the loss of ON responses in vitro
To determine if the shift towards OFF dominated responses can be the
consequence of changes in the input to the SC, I evaluated the spontaneous and
visually evoked responses in Tg P23H-1 rat RGCs using an MEA in vitro. MEA
recordings were made from both WT and from Tg P23H-1 RGCs at P35 and
P300. Only 60% of the RGCs in the P300 Tg P23H-1 were visually responsive
compared to 96.8% and 98.7% for P35 Tg P23H-1 and WT rats respectively. In
WT rats, the RGC profile is 37% ON RGCs, 41% OFF, and 21% ON-OFF RGCs.
Only one RGC (2%) was unresponsive to visual stimuli in WT rat retina. The P35
Tg P23H-1 retinas showed a similar RGC response profile; there were relatively
equal proportions of ON (37%) and OFF RGCs (36%), a smaller proportion of
ON/OFF RGCs (25%) and very few visually non-responsive RGCs (3%). In the
P300 Tg P23H-1 retinas the portion of ON or ON-OFF RGCs (2%) was greatly
reduced, while OFF type RGCs were still abundant in P300 Tg P23H-1 retinas
(Figure 33). In addition, there were a large proportion of non-responsive cells in
the P300 retinas (40%). Also of note, the total percent of OFF cells is relatively
similar across the three groups, at ~40-45%. This indicates that RGCs are not
changing their response characteristics, i.e. ON cells are not becoming OFF cells
during rewiring of the retinal circuitry. It appears that the response to light onset
is declining and producing a decrease in RGCs with either ON or ON-OFF
responses and that as this occurs there is an increase in visually non-responsive
cells, while the OFF pathway remains robust.
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Figure 33. The cell class profile
for WT, P35 and P300 Tg P23H-1
retinas. A clear change was
evident in the P300 animals while
the P35 group has a very similar
distribution as WT animals. NR =
non-responsive RGCs

Differential changes in the spontaneous activity of ON and OFF RGCs in Tg
P23H-1 rat retina.
In WT rat retina, no changes are evident in the spontaneous activity of any
RGC class as the animals age. The frequency of action potentials does not
increase with age in WT rats. No inherent peak frequency is present in the
spontaneous firing rate either. In many retinal dystrophy models spontaneous
activity often changes in frequency and/or pattern. For example, in mouse
models of RP (Stasheff 2008,Trenholm et al., 2012) and congenital stationary
night blindness (CSNB, Demas et al., 2006), changes in spontaneous activity of
RGCs have been described in the form of bursting activity and increased overall
activity. In RP models, these changes are correlated with the decline of
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photoreceptors. At P300, Tg P23H-1 OFF RGCs exhibit spontaneous activity
with a significant rhythmic component, defined by a peak F0 component when a
fast Fourier transformation (FFT) was performed. The remaining ON and ONOFF RGCs did not show a significant rhythmic component (Figure 34).

n=54

n=47

Figure 34. F0 peak of the fast
Fourier transform in P300 Tg
P23H-1 retinal cell classes. Only
OFF cells and NR cells exhibited
burst activity as evidenced by the
F0 component.

When comparing the peak of the FFT, which shows the primary rhythmic
frequency if there is rhythmic firing, OFF RGCs had an average fundamental
peak at 6.22 Hz compared to 2.92 Hz for P35 Tg P23H-1. Non-responsive P300
RGCs also showed a fundamental peak at 5.89 Hz, but this was not significantly
lower than OFF cells. This suggests the same mechanism is driving the bursting
activity in these cells. ON and ON-OFF responsive cells never had any rhythmic
activity, evident by the lack of an F0 peak in the FFT for those cells. This may
indicate differences in circuitry that lead to an early onset of rhythmicity in OFF
cells even though they are still receiving input, while ON or ON-OFF cells do not
exhibit rhythmic bursting until they become non-responsive to visual stimuli.
OFF RGCs in both P35 and P300 Tg rats trend towards an increase in
spontaneous activity, with an average firing rate of 9.97 and 11.07 Hz
respectively. However, this did not reach significance compared to WT OFF cells
at 6.61 Hz. There was a trend for a drop in ON RGC spontaneous activity for
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both Tg groups compared to WT, but again this was not a significant difference.
Sekirnjak et al. (2011) reported an increase in OFF RGC spontaneous activity
but no change in ON activity as Tg P23H-1 rats age and this data has a similar
trend.

Discussion
My data differs from previously published results describing RGC function
in the Tg P23H-1 rat (Sekirnjak et al., 2011). In light of other models of RP that
do show a shift towards OFF dominated responses (rd1, rd10, RCS rat), they
tested the Tg P23H-1 rat and concluded that there was no change in the ONOFF balance. My data show there are functional changes in both Tg P23H-1 and
Tg S334ter-3 rat models of RP. While the Tg P23H-1 rat showed a progressive
shift from ON to OFF dominated SC responses, SC responses in the Tg S334ter3 rat were OFF dominated from the earliest age. Even though the two models are
different in this respect, there is a common loss of the ON pathway while the OFF
pathway remains robust. This change was very robust in my experiments so this
may be a consequence of a different experimental setup. Their stimulus was
white noise, which consists of a randomly flickering checkerboard of small
squares, while my stimulus was full field.
The MEA data for Tg P23H-1 suggests that the shift to OFF dominated
responses in the SC is due to a change in input from RGCs. This does not
eliminate the possibility that there are reactive changes in the SC however. In
fact, functional and structural changes in the SC of RCS rats have been reported
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previously. Vugler and Coffey (2003) reported the loss of calretinin and
parvalbumin immunoreactivity in SC neurons of RCS rats Pothecary et al. (2005)
reported altered SC expression of iGluR receptors in RCS rats that led to
changes in SC responses compared to wild type rats. These examples may be
mutation specific but it is likely that the SC (and other areas of the visual system)
exhibits reactive changes during the degenerative process that is not mutation
specific.
This functional change from ON to OFF dominated responses appears to
be a consequence of photoreceptor degeneration in general, rather than specific
to certain RP models. This is the fourth description of such a change and the
third mutation (Mertk, Pde6, and now rhodopsin) in which this change is
occurring. Similar to the Tg S334ter-3, the rd1 (Pde6 mutation) is a very rapid
decline, yet still shows a similar preferential loss of the ON pathway. It could be
argued that this may be specific to rodent models since all of the above
examples are either rat or mouse but unpublished data from the McCall
laboratory shows evidence of a similar change in a pig model of RP (also the
P23H mutation). If this is something universal to photoreceptor degeneration, it
may be possible to exploit this change in the clinic to either diagnose early
stages of RP or AMD and also to assess the speed of disease progression,
perhaps looking at changes in threshold responses of patients to light increments
and decrements. Renner et al. (2006) reported that there was a larger decrease
in the ON ERG response vs. OFF response in humans with various retinal
dystrophies thought not in RP patients. This was a small sample but does
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support the possibility that a differential change in the ON vs. OFF pathway is
detectable in the clinic.
Since this functional change appears across multiple models with different
mutations (rd1-Pde6, RCS-Mertk, P23H/S334ter –rhodopsin), a more universal
explanation is likely to account for these changes. My hypothesis is that the loss
of expression of mGluR receptors is a protective mechanism for ON BCs. As
photoreceptors are lost, glutamate release onto the terminals of the horizontal
and BC dendrites must decline. Since ON BCs respond in a sign inverting
manner to glutamate, the absence of glutamate may keep these ON BCs in a
depolarized condition. If this is the case and there are no compensatory
mechanisms, the time the TrpM1 channel is in its open state should increase and
the constant depolarized state should increase intracellular calcium potentially
leading to excitotoxicity and eventually cell death if the depolarization is not
corrected. As there is no precedence for a selective cell death of ON vs. OFF
BCs, it is likely that the ON BCs may eliminate expression of the mGluR6
receptor either by a reduction in trafficking to the cell surface or down regulation
of expression in general. In contrast, OFF BCs express ionotropic glutamate
receptors, which are sign conserving so the loss of glutamate is a lack of
depolarization. In this case, there would be no excitotoxicity that would cause
OFF BCs to stop expressing iGluR on their dendritic tips. In addition, the nob
mouse does not show the same change glutamate receptor expression (Ball et
al., 2003) even though there is a lack of response from ON BCs. The nob mouse
is a model for congenital stationary night blindness in which the protein
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nyctalopin is mutated, which is required for the localization of TrpM1 channels to
the ON BC dendritic tips. Photoreceptors in the nob mouse are still functional, as
evidenced by the presence of an a-wave, so BCs still receive input but this input
no longer results in membrane voltage changes in ON BCs. This suggests that
the mechanism depends on input from photoreceptors and the presence of a
functional TrpM1 channel for expression to change. Without functional TrpM1
channels, there is no depolarization in ON BCs and therefore no excitotoxicity in
nob. Therefore, the mechanism that reduces mGluR6 expression is never
initiated in the ON BCs of the nob mutant. I believe this supports the idea that the
lack of input from photoreceptors is causing the reactive changes seen in RP
models.
These functional changes also have important implications for future
treatments. For example, if stem cells are able to integrate into a host retina, how
can we be certain that the retina will respond properly if there is significant
remodeling in structure and function? If this change does represent a
modification in the expression of glutamate receptors, as has been previously
reported, then the release of glutamate from newly integrated photoreceptors
may be ineffective. It’s possible that a feedback mechanism may exist if
photoreceptors are reintroduced to the system, causing the BCs to express their
normal glutamate receptors again but this has not been reported to occur.
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CHAPTER IV
IMPLANTATION OF RETINAL PROSTHETIC
DEVICES IMPARTS A FUNCTIONAL
NEUROPROTECTIVE EFFECT

Introduction
When a cure is not available, an important strategy in treating
neurodegenerative disease is to slow its progression. The mPVA device has
been observed to exhibit neuroprotective effects by preservation of photoreceptor
numbers (Pardue et al., 2005) and as light evoked responses recorded in the SC
(DeMarco et al., 2007). There is evidence that electrical stimulation, in general,
provides a neuroprotective effect with an increase in ONL thickness and ERG awave and b-wave amplitude (Morimoto et al., 2005, Morimoto et al., 2007, Ni et
al., 2009, Morimoto et al., 2012). The question remains however, does
preservation have functional implications that have not been previously tested?
In cases where there was preservation, the benefit was often transient, delaying
degeneration for a short time (1-2 weeks) (Morimoto et al., 2007, Ciavatta et al.,
2009). This does not preclude the possibility that an effect on the retina still exists
after photoreceptors are lost. This could be in the form of preservation of the
remaining cellular layers (INL, RGC), receptor expression (mGluR, Glycine,
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GABA), or RPE structure as RPE cells often invade other cellular layers during
the degenerative process. The possibility of a prosthesis-mediated
neuroprotective effect has important implications for the timing of surgery in a
patient. If there is a long-term functional preservation of visual responses or if
cells or the structure of the retina is preserved, it may mean implantation at an
earlier stage of degeneration may be beneficial. Alternatively, if there is no
protective effect, surgery may be best left until late stages of the disease when
the risk to the patient is minimized. Although I did not perform a stimulation
protocol in the implanted rats, it is possible that the low level of current generated
by the implant with ambient lighting conditions may stimulate the retina enough to
support neuroprotection.

Experimental Goal
The goal of these experiments was to determine if there is any effect on
the visually-evoked response recorded in the SC when a prosthetic device is
present. With the ON-OFF response changes described in Chapter III for both
RP models, a neuroprotective effect is defined here as a significant increase in
the function of the ON pathway. In WT, both the ON and OFF pathways are
functional and stable with age. In both models, the OFF pathway dominates the
degenerate retina, either early in the process (Tg S334ter-3) or as the animals
age (Tg P23H-1). The implication for degenerative diseases, if this is a common
symptomatic change, is that without a functional ON pathway, treatment options
may be limited in their potential for normal vision.
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Materials and Methods
Animals
Three groups of Tg P23H-1 and Tg S334ter-3 animals were used in these
experiments. One group of Tg P23H-1 was implanted with bPVA devices and
tested. Two groups of Tg S334ter-3 animals were tested; one group implanted
with bPVA devices and the other implanted with mPVA devices.
Implantation Surgery
The same protocol was used as described in Chapter II. Animals were
implanted at ~P35 for both Tg models. This age is very early in the degenerative
process for the Tg P23H-1 rat when responses are similar to WT. Only a small
loss of ONL thickness is evident at this age, with ~12 rows of nuclei remaining vs.
~15 rows in WT rats. The Tg S334ter-3 responses were already significantly
different from WT at this age, but this is as early as the rats will easily tolerate
anesthesia and surgery to make a full recovery. In addition, there are still 3-5
rows of nuclei at this age, allowing some degeneration to still take place before
experiments were carried out. Tg S334ter-3 were ~P75 and Tg P23H-1 were
~P150 at the time of recording since these time points represent when retinal
function is significantly different from WT rats for both groups.

In Vivo Electrophysiology
These experiments borrow elements from both Chapter II and III for the
electrophysiology. Data was collected and analyzed in a similar fashion using an
XCell3 Microelectrode Amplifier (FHC) into a Power 1401 data acquisition unit
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(CED). Data was collected and stored on a computer running Spike2 (CED) and
analyzed offline. To assess the function as it related to the region of implant
influence, the visually evoked responses were mapped using the same hemi-field
LED stimulus for the right eye and the IR evoked responses were mapped using
the IR laser system. This allowed for a retinotopic map of both visual and IR
evoked responses and for regions under the influence of the prosthesis to be
compared to regions outside the influence of the prosthesis. To examine whether
there is a trophic effect, Tg P23H-1 rats were implanted with a bPVA device. The
Tg P23H-1 group was implanted with bPVA devices for this specific set of data
while Tg S334ter-3 data was gathered from animals implanted for data in
Chapter II. I recorded and characterized the prosthetic and visually evoked
responses in the SC and examined whether there was evidence of a
neurotrophic effect by comparing the visually evoked responses within animals
depending on the proximity to PVA influence. In addition, these responses were
compared with responses of non-implanted controls whose ages were matched
to the age at the endpoint of implantation (~P140-150). I used full field visible
stimuli and the IR laser and recorded these evoked responses in a systematic
map across the SC dorsal surface. I compared visually evoked responses, which
changed significantly with disease progression (see Chapter III for detailed
analysis): the shift in the ON-OFF index and spontaneous activity levels.
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Results
Implantation of a bPVA device imparts a neuroprotective effect in the Tg P23H-1
rat retina
In the Tg P23H-1 rat model, there is a prolonged decline in visually
evoked responses, a change in spontaneous activity of OFF and non-responsive
(NR) RGCs (bursting activity), as well as a shift from ON dominated responses to
OFF dominated responses (See
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signaling and input to the SC. To
200 µm

determine if there was a functional

Figure 35. Schematic diagram of IR,
Near and Far site designation. The
red circle represents the IR
responsive sites, the green circle
excluding the red circle represents
near sites (<400 µm) and outside the
green circle are far sites (>400 µm).

neuroprotective effect of implantation,
I divided the SC into regions based on
how close they were to the SC area

where IR-evoked responses could be recorded. Figure 35 shows an example of
how these areas were calculated. Comparisons were made between areas that
showed direct IR-evoked responses, areas adjacent to (<400 µm) PVAresponsive sites, and areas far away from the area of PVA influence (>400).
Figure 36 shows an example of the two topographic responses maps of a Tg
P23H-1 SC at P140. The maps were created from the IR-evoked responses
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(black and white) and visually evoked response plotted as the ON-OFF indices
(color map with peak index value = red and lowest index value = blue). The large
map shows the superimposition of the two individual maps. In the region of
overlap, the ON-OFF index is highest for this animal, indicating there may be a
correlation between the region of PVA influence and the function of the ON
pathway.
To evaluate whether this neurotrophic effect was confined to the are
directly in contact with the implant or a paracrine effect that could encompass the
entire retina, I compared the average ON-OFF index within IR responsive in the
Tg P23H-1 SC sites to SC sites adjacent (<400 µm) or distal (≥400 µm) to this
area in P150 animals. Figure 37 plots the ON-OFF index in relation to the PVA
influence and shows that SC responses shift significantly towards balanced ON
and OFF responses. Regardless of their distance from IR responsive areas, the
areas outside of the influence of the device remained OFF dominant and did not
differ significantly from one another. This indicates that the neurotrophic effect
was limited to regions that are directly under the influence of the PVA, rather than
a global effect.
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Peak IR
Response

Unresponsive
(Black)

Peak Visual
Response

Unresponsive
(Black)

Figure 36. Example SC topographic
maps from the same Tg P23H-1
animal. The black and white map
represents IR responsive sites in
white. The color map represents ONOFF index values, with the highest
index values in red and low values in
blue. The maps were then
superimposed to show the
relationship between the IR
responsive region and the ON-OFF
index value.

Figure 37. Comparison of the
ON-OFF index and topographic
relationship between IR
responsive sites (IR), sites
adjacent to but not more than
400 µm from the IR responsive
area (Near), and sites greater
than 400 µm from the IR
responsive region (Far). .In
bPVA implanted Tg P23H-1
rats, regions under the
influence of the implant were
significantly different than
regions outside the influence of
the prosthesis. **p<0.01

As described previously (Chapter III), the ON-OFF index depends on both
peak amplitude and duration of the ON and OFF response. With this
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dependence, it is possible that rather than a protective effect on retinal function,
the effect could result from a decrease in the OFF response amplitude or
duration rather than a protective effect on the retina. To evaluate how the
presence of the prosthetic changes these aspects of the response, I compared
the amplitude and duration of the ON and OFF SC response. Figure 39 plots the
ON and OFF duration and peak responses as a function of region and shows a
significant increase in the total response of the ON response while the OFF
response was similar across areas. This suggests that the neurotrophic effect of
the device is selective to the ON pathway. The untreated Tg group was not
significantly different than the IR responsive areas. This may suggest there is no
neuroprotective effect. However, this can be interpreted in different ways and is
addressed within the discussion section below.
Figure 38 shows that there was a significant increase in the amplitude of
the response and a trend for the duration of the SC ON response to increase. In
contrast, neither component of the OFF response was different. Taken together,
there was a significant effect on the ON response in areas under the influence of
the device while no change was seen in OFF responses regardless of the
position relative to the bPVA. Spontaneous activity was also compared to
determine if there was any effect on the firing rate. There was no effect across
groups with implants, but the spontaneous activity of all regions of the SC was
significantly lower than that of untreated, age-matched controls (Figure 39). It is
difficult to say if this represents a protective effect as the spontaneous activity
has been reported to change in Tg P23H-1 rats depending on the RGC cell type
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(Sekirnjak et al., 2009). ON cells were reported to decrease their firing rate while
OFF cells increase their spontaneous activity. Since the experiments outlined
here are recording multicellular SC activity, it is impossible to know the functional
class that has input to a particular area of the SC. Therefore, it cannot be
determined if these changes are being mitigated by the PVA or if this was caused
by another factor, such as variance between litters (implanted animals tended to
be from the same litter).

A.

B.

Figure 38.
A. Tg P23H-1 peak amplitude comparison for the ON (left) and OFF (right)
response. **p<0.01, ****p<0.0001
B. Response duration comparison. No groups were significantly different
from one another.
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Figure 39. Comparison of the
spontaneous SC activity in Tg
P23H-1 rats as a function of
implant influence. No region of
the SC had any change in
spontaneous activity but all
regions had lower activity than
untreated rats. *p<0.05

Implantation may impart a partial recovery of the ON pathway in the Tg
S334ter-3 rat
As described in Chapter III, degeneration in the Tg S334ter-3 rat is much
more rapid than the Tg P23H-1 rat. The Tg S334ter-3 rat also showed a
significantly different ON-OFF index from WT. Even as early as the age of
implantation (P35), OFF responses dominated the SC response profile. Although
this may be a significant hurdle for a neuroprotective effect, I made comparisons
in the Tg S334ter-3 in the same manner as described for the Tg P23H-1 above.
Figure 40 plots the ON-OFF index for regions under the influence of the PVA and
regions outside of its influence and shows that despite the more aggressive
nature of the Tg S334ter-3 degeneration that the prosthetic significantly
increases the ON-OFF index in regions under its influence. There was no
significant difference between sites that are directly adjacent (<400 µm) to the
area of influence and areas more than 400 µm away, similar to the effect seen in
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Tg P23H-1 rats. When compared to untreated Tg animals, the ON-OFF index
was significantly higher for regions under the influence of the PVA.

Figure 40. ON-OFF index
comparison in relation to area of
PVA influence. Regions under the
influence of the PVA showed a
significant increase in the ON-OFF
index, even when compared to
untreated Tg rats. **p<0.01

Figure 41 plots the ON and OFF peak responses and response duration for Tg
S334ter-3 rats. Though there was a significant change in the ON-OFF index,
there was no significant change in the ON duration or peak response. There was
a trend however, towards a higher ON peak response for sites under the
influence of the PVA. This may be a consequence of a low n (5) and may be
significant if the number of rats was increased. An important point to make here
as well was the lack of change in the OFF pathway as the animals aged, the OFF
response was consistent regardless of the measurement used. Surprisingly, the
OFF response of the untreated animals was much larger than the OFF response
in implanted animals. This explains the significant change in the ON-OFF index
when compared to untreated animals. However, when the internal control regions
are compared to the IR-responsive regions, there is a trend for an increased ON
response in regions under the influence of the PVA and the ON-OFF index value
was still significantly higher in regions of PVA influence.
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Figure 41.
A. Comparison of the ON and OFF peak response in relation to regions of
PVA influence. No significant changes were found, though a trend towards
larger ON responses was seen in regions of PVA influence.
B. Comparison of the ON and OFF response duration. The OFF response
was significantly longer in untreated Tg animals. ***p<0.001, ****p<0.0001

In contrast to the change in Tg P23H-1 spontaneous activity, there was no
significant change in the spontaneous activity in Tg S334ter-3 rats either across
regions within an implanted rat or compared to untreated age-matched Tg rats
(Figure 42).
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Figure 42. Spontaneous
activity in implanted and
untreated Tg S334ter-3 rats.
No significant change in
spontaneous activity was
seen.

Discussion
My data suggest there may be a neuroprotective effect on the function of
the retina in regions under the influence of the prosthesis. In both the Tg P23H-1
and Tg S334ter-3 rat models show significantly larger ON-OFF indices in regions
within IR-evoked responses, suggesting a rescue of function within the ON
pathway. Although there are trends that indicate some change with distance, the
significant effects appear local to the region of PVA influence. This suggests that
the effect is either due to stimulation provided by the device, albeit low in level, or
the presence of a foreign object. I favor the former explanation since it is local
and not global, which would be expected from a foreign object influence. Rather,
the data suggests there is an effect directly related to contact with the PVA.
Whether this is a physical interface or functional contact (current spreading to
regions away from the PVA) cannot be determined.
My data supports the hypothesis that a prosthetic device can impart a
neuroprotective effect by prolonging ON pathway function, especially in the
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slower degenerating Tg P23H-1 rat. The results in Tg S334ter-3 rats were not
conclusive but this may be due to the length of the implantation. In the Tg P23H1 rats, the implant was left in the eye for ~115 days while in Tg S334ter-3 rats, it
was only in the eye for ~40 days. The effect may simply require a longer duration
of implantation than the 40 days used here. This time point was chosen because
the degeneration is much more rapid in the Tg S334ter-3, so it can be a difficult
balance finding an age with robust visually-evoked responses and the
implantation duration. This may be why there was simply a trend for increased
ON pathway function rather than significant difference.
In patients, if implantation enhances the maintenance of retinal function,
the long term prognosis for patients, regardless of treatment, will be better. The
data suggest it may be beneficial to implant these devices earlier in the
degenerative process, as the function of the ON pathway may be spared.
Importantly, there was no detrimental effect of the OFF pathway response with
implantation in the Tg P23H-1 rats, leading to the conclusion that there is a
general beneficial effect of implantation. While not as compelling, there still was a
trend within the ON pathway and a significant increase in the ON-OFF index of
IR responsive regions in Tg S334ter-3 rats. When taken together with the data in
Chapter III, the larger ON responses in implanted animals supports the
maintenance and/or recovery of the ON pathway, with no discernible latency in
the loss of visually evoked responses. This does not preclude the possibility that
an effect on the retina still exists after photoreceptors are lost. This could be in
the form of preservation of the remaining cellular layers (INL, RGC), receptor
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expression (mGluR, Glycine, GABA), or RPE structure as RPE cells often invade
other cellular layers during the degenerative process.
An argument could be made that the presence of the devices actually
seemed to be detrimental to the function of the retina based on the comparison
to untreated Tg animals. Indeed, there was no significant difference in any
measure between regions under PVA influence when compared to untreated
controls. However, this may be explained by light damage during the implantation
surgery. Multiple studies have shown that increased exposure to light, even
under normal ambient intensities, accelerates the degenerative process in both
RP models used here (Organisciak et al., 2003, Vaughan et al., 2003, Jozwick et
al., 2006, Thomas et al., 2007). In fact, even an exposure to bright light as short
as 1 hour has been reported to significantly accelerate photoreceptor
degeneration in the Tg P23H-1 rat (Vaughan et al 2003). In light of these reports,
it is likely that the light used to illuminate the eye during the implantation surgery
negatively affected the retina in implanted animals. The surgery typically lasted
~45 minutes, which is a significant amount of time to have a bright light illuminate
the eye. Vaughan et al. (2003) exposed two lines each of Tg P23H-1 and Tg
S334ter-3 rats to intense light (1200-1400 cd/m2) for 1-8 hours. The light source
used for implantation surgery was very bright, somewhere between 1100 and
10,000 cd/m2, certainly enough light to damage the retina. Unfortunately, the
experimental setup did not allow for comparison to the non-implanted (and
presumably non-light damaged) eye as the stereotaxic apparatus physically
impeded the ability to direct the full field light source on the opposite eye. Bearing
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this in mind, the most effective comparison would be within the same eye,
comparing areas under PVA influence to areas outside of its influence. When
these regions are compared, Tg P23H-1 ON pathway function is significantly
larger within the PVA influenced area. Although not statistically significant, the
trend is the same in Tg S334ter-3 rats.
DeMarco et al (2007) reported trophic effects of implantation of mPVAs in
RCS rats. First, visual responses were more robust in areas under the influence
of the mPVA. Secondly, there was an increase in the number of visual
responsive SC sites even in regions that were not correlated with the likely
position of the prosthesis. This may be due to a more global response to either
the surgery or foreign body response to the prosthesis. The global response
could be an increase in trophic factors, such as Fgf2 as reported by Ciavatta et
al. (2009) in the RCS rat. While an increase in trophic factors cannot be ruled out
for my data, there was no observable delay in the loss of visual responses. My
data support an alternative hypothesis. Since the effect was localized to area
under the influence of the PVA, it is more likely that the current generated by the
prosthesis results in the functional neuroprotection. While the devices are not
producing enough current to elicit PVA-evoked responses to ambient light, they
still produce current in response to ambient light (see Figure 10), albeit at a much
reduced level. The rats are housed in a normal 12/12 light-dark cycle, so there
are up to 12 hours each day that the devices are producing some basal level of
current. In addition, in both Tg models, the only areas that showed a significant
increase in the ON-OFF index were the areas directly under the influence of the
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device. This does not rule out the possibility that the electrical current elicits an
increase in trophic factors directly where it sits in the retina, but regardless, the
effect was tied to a functional connection with the bPVA. This is consistent with
reported neuroprotection using trans-corneal electrical stimulation in RCS rats
where there was a preservation of both numbers of photoreceptors and ERG
amplitudes in treated animals (Morimoto et al., 2007). It should be noted that the
RCS rat and its photoreceptor degeneration is caused by a very different
mechanism. Specifically, in the RCS rat the cells of the retinal pigment epithelium
are dysfunctional and fail to phagocytize disks shed from the outer segment of
photoreceptors. This leads to a buildup of debris in the subretinal space and a
cascade of events ending in photoreceptor death. As a consequence, the effect
of implantation may have quite different trophic effects.
The important question remains, however, what is the underlying cause of
the neuroprotective effect? Does electrical stimulation cause an increase in
trophic factors and if so, which ones? Does electrical current act directly on BCs
to change their membrane potential and if so, does it close or open ion channels
and which ones (excitatory at the dendritic or axonal tips or inhibitory at the
axonal tips)? If the hypothesis for the loss of the ON pathway described in
Chapter III is correct, then I believe my results support the theory that electrical
current acts directly on the retina, likely hyperpolarizing BCs through some
mechanism. This could prevent a reactive (excitotoxic or other) mechanism that
reduces the expression of mGluR6. Regardless, the data suggest that the
implant itself prevents the loss of the ON pathway in both of these models of RP.
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CHAPTER V
SUMMARY AND FUTURE DIRECTIONS
In summary, Chapter II described the retina-prosthesis interface with the
following conclusions:
1. Targeted prosthesis stimulation yields a high success rate for retinal activation.
2. Synaptic blocker injections show PVA-evoked responses are mediated
through INL neurons rather than through direct activation of RGCs.
3. Activation in the SC is generally correlated to the location of the device in the
eye.
4. Implantation age and duration had no effect on threshold for stimulation.
5. Pixel size in bPVA devices did not affect threshold but bPVA devices had a
significantly higher threshold for activation than mPVA devices.
6. All thresholds for activation were below established safety limits for the retina.
7. A linear range of increasing PVA-mediated responses was present.
8. Focal activation of the retina was possible with bPVA devices but not mPVA
devices.
9. The bPVA device design represents a significant improvement in prosthesis
design of the mPVA design.
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One of the major hurdles to treating RP is the heterogeneity in the cause
of the disease. The cost for a company to develop genetic treatments for every
cause of RP is not cost effective for these companies. More comprehensive
treatments that are independent of the cause are most likely to be developed on
a commercial basis. To this end, the use of prosthetic devices, stem cells, and
optogenetic tools likely represent the most promising options. When safety
concerns are considered, currently prosthetic devices have been deemed safe by
the FDA while both stem cells and optogenetic manipulation still have concerns
and questions that have yet to be addressed. In addition, the state of the retina
may guide which treatments will be most effective for a given patient. If BCs are
unable to faithfully transmit signals mediated by glutamate, prosthetic devices will
still work at either the BC or RGCs level.
The Argus II system developed by Second Sight, Inc. is an epiretinal
design that is the only retinal prosthesis to be approved by the FDA. It has a
proven track record with years of research to back up its safety and efficacy.
However, the best resolution achieved with this device is quite poor, only
reaching 20/1260. The prosthesis group in Germany led by Dr. Zrenner has
achieved a much higher resolution (20/560) with their subretinal implant.
However, both systems rely on an external power supply. Both of these issues
are addressed by the bPVA design. It is a subretinal chip that has the potential
for high acuity vision while being completely self-contained. The debate between
subretinal and epiretinal prosthetic designs is still ongoing with both systems
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having their advantages and disadvantages. In my opinion, subretinal stimulation
using a photovoltaic array offers the best design for a retinal prosthetic device.
The future of the retinal prosthesis field will undoubtedly be higher
resolution designs. A thorough understanding of what vision is possible with
visual prosthetics will also drive future designs and stimulus protocols. While
forms, luminance and rudimentary motion can be encoded by current designs,
the visual system encodes much more information than these basic perceptions.
Can other facets of vision be faithfully encoded such as color vision, depth
perception, and ON/OFF signals? Regardless of this outcome to these questions,
prosthetic devices have been proven safe, can transmit information to completely
blind patients, and have long term stability.

Chapter III described functional changes associated with photoreceptor
degeneration and concluded the following:
1. In the Tg P23H-1 rat model of RP, there is a shift in SC responses from ON
dominated to OFF dominated that increases as a function of age.
2. In the Tg S334ter-3 rat model of RP, SC responses are strongly OFF
dominated from a very early age likely due to the rapid nature of this model’s
degeneration.
3. MEA recordings in Tg P23H-1 rat retina indicate that the progressive changes
are caused by the loss of ON signaling within the retina rather than changes
within the SC.
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4. An increase in spontaneous activity and rhythmic activity in Tg P23H-1 RGCs
are only seen in OFF and NR RGCs once photoreceptors have begun to
degenerate.

The functional consequences of photoreceptor degeneration have not
been extensively explored. The state of the retina during the degenerative
process may have profound effects on the potential for certain treatments to be
effective. If we can categorize these changes, future research can work to either
prevent or reverse these changes and better treat patients with degenerative
diseases such as RP and AMD. In addition, studying the reactive changes in the
retina may be beneficial towards understanding plasticity within the retina. Other
species, such as chickens (Fisher, 2005) and frogs (Filoni, 2009), are able to
regenerate cells within the retina if they are damaged. Some of the processes
that occur during the degenerative process may be common to proliferative or
developing cells. In this regard, studying the mechanisms of these reactive
changes may help discover why mammalian retinas (and neurons in general) are
unable to regenerate and how plasticity in the retina may be encouraged and
utilized.

Chapter IV described a possible functional neuroprotective mechanism
through implantation of a prosthetic device with the following conclusions:
1. Implantation of bPVA devices significantly increased the function of the ON
pathway in Tg P23H-1 rats.
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2. The effect was present only in SC regions that were under the influence of the
PVA.
3. Implantation in Tg S334ter-3 rats showed a similar trend for an increased ON
response but only was significantly different when analyzing the ON-OFF index.
Electrical stimulation of the retina may be an effective neuroprotective
mechanism, whether applied directly to the retina or by stimulating the whole
eye. The functional recovery described in this chapter was only present in
regions under the influence of the PVA. This suggests that this example of
functional neuroprotection may not be possible using external stimulation of the
retina. If the current was increased, this may be enough to see a similar effect.
The results with the Tg S334ter-3 rats were not as strong as in implanted Tg
P23H-1 rats, but as previously discussed, this may be due to the difference in
implantation duration. Alternatively, the rapid degeneration and loss of the ON
pathway in the Tg S334ter-3 may prevent electrical stimulation from being
effective in this model. For the majority of RP patients, this is a slow process with
many patients not being severely impaired until late in life. As such, the Tg P23H1 rat probably represents a more analogous model of RP than the Tg S334ter-3.
If the effect is truly mediated by the current generated by the device, the next
logical step would be to actively stimulate the device with IR light over the course
of a few weeks (or months) to see if the effect is related to the amount of current
generated by the PVA. This may enhance the effect and increase the ON
response even further. In addition, even if the progression of the disease is not
slowed or halted, if the retinal circuitry is spared during the degenerative process,
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such as the expression of mGluR6 on BCs, this can increase the treatment
options and effectiveness for a patient.
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